
==== Front
Adv Nutr
Adv Nutr
Advances in Nutrition
2161-8313
2156-5376
American Society for Nutrition

S2161-8313(24)00111-X
10.1016/j.advnut.2024.100277
100277
Review
Nutritional Modulation of Host Defense Peptide Synthesis: A Novel Host-Directed Antimicrobial Therapeutic Strategy?
Whitmore Melanie
Tobin Isabel
Burkardt Amanda †
Zhang Guolong zguolon@okstate.edu
⁎
Department of Animal and Food Sciences, Oklahoma State University, Stillwater, OK, United States
⁎ Corresponding author. zguolon@okstate.edu
† Present address for AB: Phiogen, 2450 Holcombe Blvd, Suite BCMA 1.01, Houston, TX.

23 7 2024
9 2024
23 7 2024
15 9 10027728 2 2024
11 6 2024
19 7 2024
© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
The escalating threat of antimicrobial resistance underscores the imperative for innovative therapeutic strategies. Host defense peptides (HDPs), integral components of innate immunity, exhibit profound antimicrobial and immunomodulatory properties. Various dietary compounds, such as short-chain fatty acids, vitamins, minerals, sugars, amino acids, phytochemicals, bile acids, probiotics, and prebiotics have been identified to enhance the synthesis of endogenous HDPs without provoking inflammatory response or compromising barrier integrity. Additionally, different classes of these compounds synergize in augmenting HDP synthesis and disease resistance. Moreover, dietary supplementation of several HDP-inducing compounds or their combinations have demonstrated robust protection in rodents, rabbits, pigs, cattle, and chickens from experimental infections. However, the efficacy of these compounds in inducing HDP synthesis varies considerably among distinct compounds. Additionally, the regulation of HDP genes occurs in a gene-specific, cell type–specific, and species-specific manner. In this comprehensive review, we systematically summarized the modulation of HDP synthesis and the mechanism of action attributed to each major class of dietary compounds, including their synergistic combinations, across a spectrum of animal species including humans. We argue that the ability to enhance innate immunity and barrier function without triggering inflammation or microbial resistance positions the nutritional modulation of endogenous HDP synthesis as a promising host-directed approach for mitigating infectious diseases and antimicrobial resistance. These HDP-inducing compounds, particularly in combinations, harbor substantial clinical potential for further exploration in antimicrobial therapies for both human and other animals.

Keywords

host defense peptides
antimicrobial peptides
antimicrobial resistance
host-directed antimicrobial therapy
nutritional regulation
Abbreviations

AP activator protein

AvBD avian β-defensin

cAMP cyclic adenosine monophosphate

CAMP cathelicidin

COX cyclooxygenase

CREB cAMP-response element-binding protein

DEF defensin

DEFA α-defensin

DEFB β-defensin

DNMT DNA methyltransferase

EGCG epigallocatechin gallate

EGF epidermal growth factor

ERK extracellular signal-regulated kinase

FSK forskolin

HAMP hepcidin antimicrobial peptide

HDAC histone deacetylase

HDP host defense peptide

HMT histone methyltransferase

LCA lithocholic acid

LEAP liver-enriched antimicrobial peptide

MAPK mitogen-activated protein kinase

PBA phenylbutyrate

PBD porcine β-defensin

SCFA short-chain fatty acid

SIRT sirtuin

STAT signal transducers and activator of transcription

TLR Toll-like receptor

VDR vitamin D receptor
==== Body
pmc Statement of Significance

This review systematically categorizes various dietary compounds capable of inducing host defense peptides by synthesizing a large body of evidence and further summarizes the mechanistic underpinnings of each compound class. This review provides a foundation for future work aimed at developing these compounds as innovative antibiotic alternatives for disease control and prevention, addressing the escalating challenge posed by antimicrobial resistance.

Introduction

The pervasive and indiscriminate usage of antibiotics in human health care and agriculture has led to the emergence of antibiotic-resistant bacteria that are associated with ∼700,000 annual deaths globally [1,2]. Antibiotic resistance has become a major public health concern, arising from the ability of bacteria to survive and proliferate in the presence of antibiotics. Evolutionarily, bacteria exposed to antibiotics experience selective pressure, allowing resistant strains to thrive and multiply through mutation and horizontal gene transfer [3,4]. Biochemically, bacteria gain resistance through mechanisms such as producing enzymes that degrade antibiotics, altering targets for antibiotics, reducing the influx of antibiotics, and increasing the expression of efflux pumps to expel antibiotics [3,4].

In human medicine, antibiotic resistance complicates the treatment of infections, leading to longer hospital stays, higher medical costs, and increased mortality [5]. In veterinary science, the widespread use of antibiotics in livestock for growth promotion and disease prevention contributes to the emergence of resistant bacteria, which can transfer to humans through direct contact or the food chain [6]. A coordinated One Health approach across human health and veterinary medicine sectors is required to preserve the efficacy of current antimicrobials while novel approaches are developed to control infectious diseases [7]. A pressing need exists for novel approaches in the face of rapid resistance development. Modulation of the synthesis of host defense peptides (HDPs), also known as antimicrobial peptides, has emerged as a promising host-directed antimicrobial strategy [8,9].

HDPs, characterized by their short, positively charged, and amphipathic features, constitute an integral component of innate immunity across a wide spectrum of life forms, ranging from mammals, amphibians, and birds to plants, fungi, and bacteria [10,11]. Two major families of HDPs, namely cathelicidins and defensins (DEFs), are produced in vertebrate animals [[10], [11], [12]]. Cathelicidins are distinguished by the presence of a highly conserved cathelin precursor sequence that undergoes enzymatic cleavage to attain biological activity, while DEFs are defined by the conservation of multiple cysteines in defined positions forming intramolecular disulfide bonds [12]. The synthesis of HDPs is predominantly orchestrated by cell types in direct contact with invading pathogens, such as mucosal epithelial cells, neutrophils, and macrophages [12]. HDPs are either constitutively produced for constant host surveillance and protection or inducibly expressed in response to infection or inflammation [12].

As critical components of innate immunity, HDPs exhibit not only a direct antimicrobial activity against a broad spectrum of pathogens but also multifaceted immunomodulatory properties [[10], [11], [12]]. Their primary antimicrobial mechanism involves membrane disruption through electrostatic interactions with negatively charged microbial membranes, followed by membrane disruption and cell lysis owing to the amphiphilic nature of HDPs [[10], [11], [12]]. Additionally, HDPs play pivotal roles in orchestrating immune responses to pathogen invasion by recruiting different types of immune cells to the sites of infection through direct chemoattraction or stimulation of chemokine secretion [12]. Specific HDPs further contribute to host immune responses to pathogens by promoting phagocytosis or the formation of neutrophil extracellular traps [12]. Moreover, certain HDPs have demonstrated ability to neutralize bacterial endotoxins, modulate host signaling pathways, or promote wound healing to reduce inflammation and facilitate tissue repair [12].

Despite the clinical approval of a few HDPs, such as nisin and daptomycin, challenges persist in the application of the synthetic or recombinant form of HDPs due to high production costs and suboptimal pharmacokinetics [[10], [11], [12]]. Recent years have witnessed a burgeoning interest in identifying nutritional compounds capable of inducing endogenous HDP synthesis in humans and animals. These HDP-inducing nutritional compounds, such as fatty acids, vitamins, animal acids, sugars, minerals, bile acids, phytochemicals, epigenetic modulators, probiotics, and prebiotics, have potential to offer a cost effective alternative approach to disease mitigation [8,9,13] (Figure 1). Importantly, such HDP-inducing compounds pose minimum risk of triggering antimicrobial resistance as they target the host rather than the pathogen. This review aims to systematically summarize current findings regarding the regulation of HDP synthesis by diverse classes of nutritional compounds and the underlying mechanisms. Additionally, the review highlights the potential for synergistic induction of HDPs and improved disease mitigation through a combination of compounds, thereby providing a promising avenue for optimizing host-directed therapeutic strategies.FIGURE 1 Classification of dietary compounds with the ability to induce host defense peptides. Key examples are listed in each category.

FIGURE 1

Methods

Articles referenced in this systematic review were obtained by searching PubMed for relevant, peer-reviewed, full-text articles that were published in English since the year 1980. The search terms used included (“host defense peptide∗” OR “host defence peptide∗” OR “antimicrobial peptide∗” OR defensin∗ OR cathelicidin∗ OR LL-37) AND (butyrate OR “fatty acid∗” OR vitamin∗ OR “amino acid∗” OR sugar∗ OR mineral∗ OR “bile acid∗” OR polyphenol∗ OR phytochemical∗ OR epigenetic OR probiotic∗ OR prebiotic∗ OR nutrient∗) AND (regulate OR regulation OR modulate OR modulation). References from selected articles were further scanned for relevance and inclusion.

Results

Enhancing HDP expression by different classes of dietary compounds

Fatty acids

Butyrate, propionate, and acetate are major forms of short-chain fatty acids (SCFAs) that are produced by bacterial fermentation of undigested fiber in the intestine [14]. SCFAs and butyrate in particular are capable of upregulating cathelicidin (CAMP) and β-defensin (DEFB) expressions in various cell types including human intestinal epithelia [[15], [16], [17]], lung epithelial cells [18,19], and monocytes [20,21] (Table 1). Besides humans, butyrate induces HDP expression in rodents [[22], [23], [24]], chickens [25,26], cattle [27,28], and pigs [[29], [30], [31], [32], [33]], suggesting the conservation of such an innate defense mechanism. Several butyrate analogs, such as 4-phenylbutyrate (PBA), 4-hydroxybutyrate, isobutyrate, benzylbutyrate, trans-cinnamyl butyrate, and glyceryl tributyrate, had a similar or even superior potency than butyrate in HDP induction in humans [20], rabbits [37], rats [39], and pigs [29,38]. Because of rapid absorption and metabolism of butyrate in the gastrointestinal tract, some of these butyrate analogs may have better potential for in vivo applications.TABLE 1 Induction of HDP synthesis by different classes of dietary compounds

TABLE 1Compound	Cells or tissues	HDPs	References	
Fatty acids	
 Butyrate	Human HT-29, SW620	CAMP	[15,16]	
	Human HT-29, Caco-2	DEFB4	[17]	
	Human A549	DEFB1	[18]	
	Human EBC-1, THP-1	CAMP	[[19], [20], [21]]	
	C57BL/6 mouse spleen	Camp	[22]	
	Mouse Paneth cells	Defa1, Defb1, Reg3g	[23,24]	
	Chicken HD11, HTC, primary monocytes, bone marrow cells, crop, jejunum, and cecum explants	AvBD3, AvBD4, AvBD5, AvBD8, AvBD9, AvBD10, AvBD14, CATHB1	[25,26]	
	Bovine MEC	DEFB5, DEFB10, TAP, LAP	[27]	
	Bovine MAC-T	DEFB5	[28]	
	Porcine IPEC-J2, 3D4/31, primary monocytes	PBD2, PBD3, PG1-5, PEP2C	[29]	
	Porcine ileum and colon, 3D4/2	PBD2, PBD3, PG1-5, PMAP37, PR-39	[30]	
	Porcine PK-15	PBD3, PBD115, PBD123, PBD128, PEP2C	[31]	
	Porcine IPEC-J2, jejunum, cecum	PBD3, PEP2C	[32,33]	
 Free fatty acids and their derivatives	Human HT-29, U937	CAMP	[20]	
Human SZ95 sebocytes	DEFB4	[34]	
	Porcine IPEC-J2	PBD2, PBD3, PEP2C	[29]	
	Chicken HD11, primary monocytes	AvBD9	[35]	
 4-Phenylbutyrate	Human VA10, U937, A498, HT-29	CAMP	[36]	
	Human VA10	DEFB1	[36]	
	Rabbit lung and rectum epithelium	CAMP	[37]	
	Porcine IPEC-J2	PBD1, PBD3, PEP2C	[38]	
 4-Hydroxybutyrate	Rat bone marrow–derived macrophages	Camp, Defb4	[39]	
 Isobutyrate, propionate	Human SW620 colonocytes	CAMP	[15]	
 Valproic acid	Human A549	DEFB1	[18]	
 Caprylic acid, nonanoic acid	Porcine IPEC-J2	PBD1, PBD2	[40]	
 Oleic acid	Mouse hair follicle sebaceous glands	Defb1	[34]	
 Propionate, hexanoate	Bovine MEC	TAP	[41]	
Vitamins	
 Vitamin D-3	Human keratinocytes, monocytes, neutrophils, neutrophil progenitors, SCC25, Calu-3, U937, HL60, bone marrow cells, HaCat, HT-29, airway epithelial organoids	CAMP	[[42], [43], [44], [45], [46], [47]]	
	Human SCC25, Calu-3, primary keratinocytes	DEFB4	[42]	
	Murine intestinal organoids	Defa5, Reg3g	[48]	
	Chicken embryonic intestinal epithelial cells and PBMCs	Multiple β-defensins	[49]	
	Bovine MEC	DEFB1, LAP, S100A7	[50]	
	Bovine peripheral blood leukocytes	DEFB3, DEFB7, DEFB8, DEFB10, LAP, S100A8	[51]	
 Calcipotriol	Human skin biopsies	CAMP	[52]	
 Retinoic acid	Human Bronchial Epithelial Cells	DEFB3, DEFB4, CAMP	[53]	
	Human U937	CAMP	[54]	
	Murine intestinal organoids	Defa5, Reg3g	[48]	
	Mouse Preadipocytes 3T3-L1	Camp	[55]	
 Retinol, retinaldehyde	Mouse skin	DEFB3	[56]	
 Nicotinamide	Human neutrophils	CAMP	[57]	
	Mouse bone marrow cells	Camp	[57]	
 Niacin	Piglet ileum, jejunum, colon	PBD2, PG1-5, PR39	[58,59]	
 Vitamin C	Human keratinocytes	DEFB1	[60]	
	Digestive gland of Haliotis discus hannai	DEFB	[61]	
Amino acids	
 Isoleucine	Human HCT-116 colon cells	DEFB1	[62]	
	Human A549 lung epithelial cells	DEFB4	[63]	
	BALB/c mouse lung	DEFB3, DEFB4	[63]	
	Bovine MDBK kidney cells	Bovine β-defensins	[64]	
	Porcine IPEC-J2	PBD1, PBD2, PBD3	[65]	
	Porcine IPEC-J2, jejunum and ileum	PBD1, PBD2, PBD114, PBD129	[66]	
	Intestine of P. vachelli × L. longirostris	DEFB, HAMP	[67]	
 Leucine	Piglet jejunum and ileum, IPEC-J2	PBD1, PBD2, PBD114, PBD129	[66]	
	Intestine of P. vachelli × L. longirostris	DEFB	[68]	
 Valine	Piglet jejunum and ileum, IPEC-J2	PBD1, PBD2, PBD114, PBD129	[66]	
 Tryptophan	Mouse ileal mucosa	Reg3g, Reg3b	[69]	
	Rat jejunal and ileal mucosa	Defb2	[70]	
	Porcine IPEC-J2	PBD1, PBD2, PBD3, PBD115, PG1-5, PR-39	[70]	
	Piglet jejunal, ileal, colon mucosa	PBD2	[71]	
 Threonine	Porcine IPEC-J2	PBD1, PBD2, PBD3	[72]	
	Head kidney of Ctenopharyngodon idella	DEFB1, HAMP, LEAP-2B	[73]	
	Spleen of Ctenopharyngodon idella	DEFB1, HAMP, LEAP-2A, LEAP-2B	[73]	
 Arginine	Human HCT-116 colon cells	DEFB1	[62]	
	Mouse Paneth cells	Defa29	[74]	
 Glutamine	Mouse Paneth cells	Reg3γ	[74]	
	Mouse ileum	Defa4	[75]	
Sugars	
 Lactose	Human HT-29, Caco-2, T84, THP-1	CAMP	[76]	
	Chicken HD11 macrophages	AvBD9, AvBD14	[77]	
	Piglet jejunal mucosa	PBD1, PBD2, PBD3	[78]	
 Glucose	Human NHK keratinocytes	DEFB1, CAMP	[60]	
	Human HEK-293, HCT-116	DEFB1	[79]	
	Rat kidney	DEFB1	[80]	
	Chicken HD11 macrophages	AvBD9, AvBD14	[77]	
 Maltose, trehalose	Human HT-29 colon epithelia	CAMP	[76]	
 Galactose	Chicken HD11 macrophages	AvBD9, CATHB1, AvBD14	[77]	
 Trehalose	Chicken HD11 macrophages	AvBD9, CATHB1	[77]	
 Maltose, sucrose, fructose	Chicken HD11 macrophages	AvBD9	[77]	
Minerals	
 Zinc	Human Caco-2	CAMP	[81]	
	Porcine IPEC-J2	PBD1, PBD2, PBD3	[65]	
 Zinc gluconate	Human skin explants	DEFB4, Psoriasin	[82]	
 Calcium	Primary human keratinocytes	DEFB3, DEFB4, DEFB104	[83]	
	Human HaCaT, PHK16-0b	DEFB1, DEFB3	[84]	
Bile acids	
 LCA	Human HT-29, keratinocytes	CAMP	[16,85]	
 CDCA, UDCA	Human biliary epithelial cells	CAMP	[86]	
 TMCA, THDCA	Mouse 3T3-L1 adipocytes	Camp	[87]	
Phytochemicals	
 EGCG	Human B11 gingival epithelial	DEFB1, DEFB4	[88]	
	Human BEAS-2B	DEFB3	[89]	
	Porcine IPEC-J2	PBD1, PBD2	[90]	
	Chicken PBMCs	AvBD9	[91]	
 Quercetin	Human HepG2 hepatocytes, rat liver	HAMP	[92]	
	Chicken HTC, PBMCs	AvBD4-7, AvBD9, AvBD14	[91]	
	Chicken ileum	Multiple β-defensins	[93]	
	Zebrafish liver	Defensin, LEAP2	[94]	
 Saponarin	Human HaCaT keratinocytes	CAMP	[95]	
 Apigenin	Human HaCaT keratinocytes	CAMP, DEFB1, DEFB3, DEFB4	[96]	
 Genistein	Human keratinocytes	CAMP	[97]	
 Xanthohumol	Porcine 3D4/31 macrophages	PBD3, PEP2C, PG1-5	[98]	
	Porcine jejunal explants	PBD3, PG1-5	[98]	
 Calycosin	Porcine IPEC-J2	PBD2, PBD3, PEP2C	[98]	
 Datiscetin	Chicken HTC, jejunal explants	AvBD9	[99]	
 Isoloquiritigenin	Human Caco-2 colonic epithelial	DEFB3	[100]	
	Porcine IPEC-J2	PBD3, PEP2C, PG1-5	[98]	
 Resveratrol	Human HepG2 hepatocytes, rat liver	HAMP	[92]	
	Human periodontal ligament	DEFB4, DEFB3	[101]	
	Human HaCaT keratinocytes, U937	CAMP	[102,103]	
	Mouse ileum	Defa3, Defa5, Defa20	[104]	
	Rat liver	Hamp	[92]	
	Chicken PBMCs	AvBD9	[91]	
 Polydatin	Human HaCat keratinocytes	DEFB4	[105]	
 Pterostilbene	Human U937 monocytes	CAMP	[103]	
	Porcine 3D4/31 macrophages	PBD3, PG1-5	[98]	
 Isorhapontigenin	Porcine IPEC-J2 intestinal epithelial	PBD3, PEP2C, PG1-5	[98]	
	Porcine jejunal explants	PBD3, PG1-5	[98]	
 Ellagic acid	Human gingival epithelial	DEFB4	[106]	
 Caffeic acid	Mouse tongue	Defb3	[107]	
 Anacardic acid	Chicken PBMCs	AvBD9	[91]	
 Curcumin	Human U937 monocytes, HT-29	CAMP	[108]	
	Grass carp liver, PBMCs	HAMP, LEAP-2, DEFB	[109]	
 Forskolin	Human HT-29, Caco-2, HaCaT, INT407, A549	CAMP	[110]	
	Chicken HD11, HTC macrophages	AvBD9	[26]	
 Andrographolide	Human Caco-2 colonic epithelial	DEFB3	[100]	
 Oridonin	Human Caco-2 colonic epithelial	DEFB3	[100]	
 Tetrandrine	Chicken HTC cells, jejunal explants	AvBD9	[99]	
 Sanguinarine	Chicken HTC cells, jejunal explants	AvBD9	[99]	
 Deoxyshikonin	Porcine IPEC-J2, 3D4/31 cells	PBD3, PEP2C, PG1-5	[98]	
	Porcine jejunal explants	PBD3, PG1-5	[98]	
Epigenetic modulators	
 Trichostatin A	Human SW620 colon epithelial	CAMP	[15]	
	Human A549 lung epithelial, human NCI-H727 lung epithelial	DEFB1	[18]	
	Human primary gingival epithelial	DEFB4	[111]	
	Human Caco-2 colonic epithelial, primary colonic	CAMP, DEFB3, DEFB4	[112]	
	Human VK2/E6E7 vaginal keratinocytes	DEFB1	[113]	
	Chicken HTC macrophages	AvBD9	[99]	
	Porcine IPEC-J2 intestinal epithelial	PBD3	[114]	
	Primary bovine mammary epithelial	DEFB3, DEFB4, DEFB7, DEFB10	[115]	
	Rat testis, cauda	Defb1, Defb2	[116]	
 Vorinostat	Human THP-1 monocytes	DEFA1, DEFA5, DEFA6, DEFB4	[117]	
	Human Caco-2/TC7 cells	DEFB4	[118]	
	Human Caco-2 and primary colonic epithelial cells	CAMP, DEFB3, DEFB4	[112]	
	Human Huh7 hepatocytes	LEAP-1	[119]	
	Porcine IPEC-J2 intestinal epithelial, porcine 3D4/31 macrophages	PBD2, PBD3	[114]	
	Chicken HTC macrophages	AvBD4, AvBD8, AvBD9, AvBD10, AvBD14	[120]	
 Entinostat	Human HT-29 colonic epithelial	CAMP	[121,122]	
	Rabbit ileal and rectal epithelium	CAMP	[121,123]	
	Chicken crop and jejunum	AvBD9, AvBD10, AvBD14, CATHB1	[124]	
 Aroylated phenylenediamines	Human HT-29 colonic epithelial	CAMP	[121]	
 ADP HO53	Human BCi and VA10 bronchial epithelial cells	CAMP, DEFB1	[125]	
 ADP HO56	Human BCi and VA10 bronchial epithelial cells	CAMP, DEFB1	[125]	
 Mocetinostat	Porcine IPEC-J2 intestinal epithelial	PBD3	[114]	
	Chicken HTC macrophages	Multiple β-defensins	[126]	
	Chicken jejunal explants	AvBD9	[126]	
	Chicken HTC and HD11 macrophages	AvBD9	[120]	
 RGFP966	Human Huh7 hepatocytes	LEAP-1	[119]	
 Panobinostat	Porcine IPEC-J2 intestinal epithelial	PBD2, PBD3, PG1-5	[114]	
 LAQ824	Porcine IPEC-J2 intestinal epithelial	PBD2, PBD3, PG1-5	[114]	
 SB939	Porcine IPEC-J2 intestinal epithelial	PBD2, PBD3, PG1-5	[114]	
 Apicidin	Human A549 lung epithelial	DEFB1	[18]	
	Chicken HTC macrophages	AvBD9	[99]	
	Porcine IPEC-J2 intestinal epithelial	PBD2, PBD3	[114]	
 Depudecin	Human A549 lung epithelial	DEFB1	[18]	
	Chicken HTC macrophages	AvBD9	[99]	
	Porcine IPEC-J2 intestinal epithelial	PBD3	[114]	
 SGI-1027	Chicken HTC macrophages	AvBD9	[120]	
 BIX01294	Chicken HTC macrophages	AvBD9	[120]	
 UNC1999	Chicken HTC macrophages	AvBD9	[120]	
 5-Azacytidine	Human gingival epithelial cells	DEFB4	[111]	
	Human OSC-19, BSC-OF, SAS, HSC-2, HSC-4, HSY oral squamous	DEFB4	[127]	
	Human HSC-3 and HSC-4 oral squamous, HaCaT keratinocytes, TR146 buccal epithelial	LL-37	[128]	
	Human VK2/E6E7 keratinocytes	DEFB1	[113]	
	Human HC-OA chondrocytes	CAMP	[129]	
	Bovine mammary epithelial	DEFB3, DEFB5, DEFB10, EBD, LAP, TAP	[115]	
	A. pernyi larvae	Attacin, cercropin, and lebocin	[130]	
	Rat cauda	Defb1, Defb2, Defb27	[116]	
	Rat testis	Defb1, Defb2, Defb30	[116]	
	Rat caput	Defb30, Defb36	[116]	
Probiotics	
 Lactobacillus gasseri	Human VK2/E6E7 keratinocytes	DEFB1	[113]	
 Lactobacillus fermentum K11-Lb3 and K2-Lb6	Human Caco-2 colonic epithelial	DEFB4	[131]	
 Ligiactobacillus salivarius SMXD51	Human Caco-2/TC7 cells	DEFB4	[132]	
 Lacticaseibacillus paracasei CBA L74	Human Caco-2 colonic epithelial	CAMP, DEFB4	[133]	
 Lactobacillus helveticus SBT2171	Human Caco-2 colonic epithelial, HSC-4 tongue epithelial	DEFB4	[134]	
	Human Ca9-22 gingival cells	DEFB3, DEFB4	[135]	
	Mouse gingival tissue	Defb4, Defb14	[135]	
 Lactobacillus rhamnosus GG	Human SW480 colonic epithelial	DEFB4	[136]	
 Bifidobacterium longum	Human SW480 colonic epithelial	DEFB4	[136]	
 L. paracasei SD1, L. rhamnosus SD4, L. fermentum SD7, L. rhamnosus SD11, L. rhamnosus GG	Primary human gingival epithelial cells	DEFB4, DEFB104	[137]	
 L. rhamnosus Lcr35	Human VK2/E6E7 vaginal epithelia	DEFB4	[138]	
 Lactobacillus crispatus	Human HeLa cells	DEFB3, DEFB4	[139]	
 Lactobacillus johnsonii NCC 533	Human epidermis	CAMP, DEFB1, DEFB4, DEFB103B	[140]	
 Lactobacillus delbrueckii subsp. bulgaricus 8481	Human serum	DEFB4	[141]	
 BB12	Human infant stool samples	CAMP, DEFB4	[142]	
 Escherichia coli Nissle 1917, Pediococcus pentosaceus, Lactobacillus acidophilus, L. fermentum	Human Caco-2 colonic epithelial	DEFB4	[143]	
 Lactobacillus reuteri 5454, B. animalis ssp.	Mouse ileum	Reg3b, Reg3g	[144]	
 L. paracasei subsp. paracasei CNCM I-1518	Rat ileum	Defb1	[145]	
 Lactobacillus casei CRF28, UW1	C57BL/6 mouse ileum	Defa-rs1	[146]	
 L. casei 32G, CRF28, BL23, M36	C57BL/6 mouse ileum	Reg3β	[146]	
 Lactobacillus plantarum ZLP001	Piglet jejunum, ileum, IPEC-J2, 3D4/31	PBD2, PBD3, PBD114, PBD129, PG 1–5, PEP2C	[147,148]	
 Lactobacillus amylovorus SLZX20-1	Porcine IPEC-J2	PBD1, PEP2C, PG1-5	[149]	
 Bacillus subtilis CP9	Porcine IPEC-J2	PG1	[150]	
 B. subtilis and L. salivarius	Piglet duodenum	PBD2	[151]	
 L. rhamnosus GG	Piglet jejunum	PBD1, PMAP-37	[152]	
 L. reuteri
Clostridium butyricum	Chicken cecum	AvBD4
AvBD1, CATH3	[153]	
 L. casei BL23	Bovine MEC	TAP	[154]	
 Saccharomyces cerevisiae CNCM I-1077	Bovine rumen and colon epithelium	DEFB1	[155]	
Prebiotics	
 Inulin	Mouse Paneth cells	Defb1, Defa1, Defa4, Defa29, Defa5, Reg3g	[24]	
 Long-chain inulin-type fructans	Mouse colon	Defb1, Camp	[156]	
 Dendrobium huoshanense polysaccharides	Mouse jejunum and ileum	Total β-defensin protein	[157]	
Abbreviations: AvBD, avian β-defensin; CAMP, cathelicidin; CDCA, chenodeoxycholic acid; DEFA, α-defensin; DEFB,β-defensin; EGCG, epigallocatechin gallate; HAMP, hepcidin antimicrobial peptide; HDP, host defense peptide; LAP, lingual antimicrobial peptide; LCA, lithocholic acid; LEAP, liver-enriched antimicrobial peptide; PBD, porcine β-defensin; Reg3, regenerating islet-derived protein 3; TAP, tracheal antimicrobial peptide; TDCA, taurodeoxycholic acid; THDCA, taurohyodeoxycholic acid; TMCA, α-tauromuricholic acid; UDCA, ursodeoxycholic acid.

Consistent with their HDP-inducing activity in cells, oral supplementation of sodium butyrate or PBA improved the clinical outcomes of shigellosis in both humans and rabbits by counteracting Shigella-induced downregulation of CAMP expression in the intestinal tract [37,158]. In chickens, dietary supplementation of butyrate significantly reduced Salmonella sp. colonization in the cecum of experimentally infected chickens [25]. Additionally, oral supplementation with sodium butyrate reduced the Corynebacterium pseudotuberculosis load, enhanced Camp expression, and alleviated lesions in the spleens of infected mice [22]. Similarly, butyrate, caprylic acid, and nonanoic acid reduced the bacterial load, mitigated intestinal inflammation, and upregulated HDP expressions in piglets challenged with Escherichia coli 0157:H7 [30,40]. A recent study also showed the ability of butyrate to counteract deoxynivalenol-mediated suppression of intestinal HDPs in weaned piglets [33].

Comparison of the HDP-inducing activity among free saturated fatty acids of 1–18 hydrocarbons in humans, pigs, and chickens revealed that SCFAs are the most potent, whereas fatty acids with longer aliphatic chains quickly lose HDP-inducing potency [20,29,39]. However, relative HDP-inducing potency of individual fatty acids varies among animal species. Butyrate appears to be the most efficacious HDP inducer in chicken and porcine epithelial and monocytic cells [29,35], whereas valerate, hexanoate, and heptanoate are capable of triggering stronger HDP expression than butyrate when used at higher concentrations in humans [20]. It will be interesting to evaluate the in vivo efficacy of valerate, hexanoate, and heptanoate and their analogs in HDP induction and bacterial clearance in humans.

It is abundantly clear that different HDPs are regulated differently by fatty acids. For example, PBA stimulated human CAMP and DEFB1 expression but not DEFB3, DEFB4, and DEFB104 in human lung epithelial cells [36]. Lauric acid, palmitic acid, and oleic acid upregulated DEFB4 but not CAMP or DEFB1 in human sebocytes [34]. In mice, oleic acid preferentially promoted the induction of mouse Defb2 in the hair follicle sebaceous glands of mouse ear skin [34]. Propionate and hexanoate potentiated bovine tracheal antimicrobial peptide expression but not DEFB5 [41].

A growing body of evidence has suggested that SCFAs and butyrate in particular induce HDP expression primarily by acting as histone deacetylase (HDAC) inhibitors [159]. HDAC1, HDAC2, and HDAC3 were downregulated by butyrate in human THP-1 monocytes [21], associated with an increase in histone acetylation along the promoters of human, bovine, and porcine HDPs, which is associated with active gene transcription [19,28,30]. Free fatty acid receptors, such as GPR41/FFAR3, GPR43/FFAR2, and GPR109a/HCAR2, are also involved in SCFA-mediated HDP induction, leading to downstream activation of the mammalian target of rapamycin and signal transducers and activator of transcription (STAT) 3 [23,160] (Figure 2).FIGURE 2 Molecular mechanisms of HDP induction by butyrate, vitamin D-3, bile acids, and lactose. An arrowhead indicates stimulation of a pathway, while a T-bar indicates inhibition of a pathway. See text for details. AC, acetyl group; AP1, activator protein-1; BRG1, Brahma-related gene 1; CDCA, chenodeoxycholic acid; C/EBPα, CCAAT enhancer binding protein α; CRE, cAMP-response element; CREB, cAMP-response element-binding protein; FXR, farnesoid X receptor; GPR, G protein-coupled receptors; HDAC, histone deacetylase; HDP, host defense peptide; LCA, lithocholic acid; MAPK, mitogen-activated protein kinases; mTOR, mammalian target of rapamycin; p50/p65, NF-κB proteins p50 and p65 heterodimer; PU.1, an ETS-family transcription factor; RXR, retinoid X receptor; SRC, steroid receptor coactivator; STAT, signal transducer and activator of transcription; TLR, toll-like receptor; UDCA, ursodeoxycholic acid; VDR; vitamin D receptor.

FIGURE 2

Additionally, Toll-like receptor (TLR) 2–mediated NF-κB activation is required for butyrate-induced expression of porcine β-defensins (PBDs) in porcine kidney and intestinal cells, while HDAC inhibition is insufficient [31,32,38]. NF-κB signaling is also required for butyrate-induced DEFB2 production by human colonic epithelial cells [118]. In fact, TLR2 expression is enhanced in bovine epithelial cells treated with butyrate, while concurrent p38 phosphorylation implicates the involvement of the mitogen-activated protein kinase (MAPK) pathway [27,28]. Canonical MAPK family members including MEK, extracellular signal-regulated kinase (ERK), and JNK regulate butyrate-induced CAMP expression in human colon, gastric, and bronchial cell lines but not in heptocarcinoma cell lines [15,36]. Furthermore, butyrate-enhanced CAMP expression in human colonic epithelial cells is mediated by PU.1, a transcription factor activated by MAPK [16]. Additional transcription factors, such as activator protein (AP) 1 and cAMP (cyclic adenosine monophosphate)-response element-binding protein (CREB), are key regulators in butyrate-induced human CAMP and DEFB4 expression [19,110,161].

Vitamins

Vitamin D-3 is a potent HDP inducer in several human cell types including epithelial cells, keratinocytes, monocytes, and neutrophils, leading to an increase in the antimicrobial activity of the host cells [[42], [43], [44], [45]]. For example, the growth of Mycobacterium tuberculosis was significantly suppressed in macrophages exposed to 1,25-dihydroxyvitamin D-3, also known as calcitriol [46,162] (Table 1 [[15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157]]). The positive influence of treatment with vitamin D-3 or its analogs on HDP production was clearly demonstrated in vivo as well. Topical treatment with vitamin D-3 resulted in the upregulation of human CAMP in acute skin injuries [52]. Similarly, psoriatic skin biopsies treated with vitamin D-3 had elevated concentrations of LL-37 and reduced proinflammatory cytokines IL-12/23 p40, IL-1α, IL-1β, and TNF-α [163].

Conversely, a deficiency in vitamin D-3 is often associated with an increased susceptibility to infections, likely due to decreased synthesis of HDPs [164]. For instance, patients who experience severe congenital neutropenia, because of a lack of vitamin D-3, experience recurrent infections, whereas patients given vitamin D-3 show restored LL-37 concentrations and reduced infections [47]. In patients with atopic dermatitis, downregulation of serum 25-hydroxyvitamin D-3 and LL-37 concentrations was observed, with a reciprocal increase in the expression of proinflammatory cytokines [165]. In patients with cystic fibrosis, serum vitamin D concentrations are often deficient, perhaps contributing to the frequency of lung infections [166]. Although serum vitamin D concentrations are positively correlated with tuberculosis disease risk [167], a recent clinical trial with 8851 children with latent tuberculosis infection found no significant improvement in disease risk when a weekly dose of 14,000 IU of vitamin D-3 was given for 3 y [168].

In addition to humans, vitamin D-3 enhances the expression of HDPs in pigs [169], chickens [49], and cattle [50,51]. Administration of vitamin D-3 to cattle reduced internalization of Staphylococcus aureus in bovine mammary epithelial cells by inducing the expression of lingual antimicrobial peptide, DEFB10, and psoriasin [50]. Similarly, an increase in expression of HDPs after vitamin D-3 supplementation was accompanied by enhanced clearance of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine in bovine peripheral blood leukocytes [51]. It is noted that there is clearly a species-specific difference in the HDP-inducing ability of vitamin D-3. Although it is a strong inducer of cathelicidins and several DEFBs in humans and cattle, vitamin D-3 fails to do so in mice, dogs, and sheep, which is likely due to an absence of the vitamin D response (VDR) elements in the promoter of HDP genes in those species [43,170]. However, intestinal α-defensins (DEFAs) appear to be regulated by vitamin D-3 in mice [48].

Vitamin D-3 induces CAMP and DEFB4 gene expression by binding to VDR to activate respective gene promoters containing VDR elements in different human cell types [42,43] (Figure 2). More recently, transcription factors PU.1 and C/EBPα were found to participate in vitamin D-3 regulation of CAMP and DEFB4 gene expression [171]. Binding of PU.1 and C/EBPα recruits Brahma-related gene 1, a component of the SWI/SNF chromatin remodeling complex, to the CAMP gene promoter, leading to an increase in H4 acetylation [171]. Additionally, steroid receptor activator 3, which has intrinsic histone acetyltransferase activity, is critical for vitamin D-3–mediated induction of CAMP, as steroid receptor activator 3 knockdown prevented the upregulation of the CAMP gene [45].

Retinoic acid, a metabolite of vitamin A, has conflicting effects on HDP induction. Retinoic acid induces CAMP, DEFB3, and DEFB4 gene expression in human bronchial epithelial cells [53] but inhibits DEFB3, DEFB4, and DEFB104 in primary keratinocytes in response to proinflammatory cytokines, bacteria, phorbol myristate acetate, or calcium [83]. Although retinoic acid induces CAMP in human U937 monocytes, no change is seen in K562 lymphoblasts [54]. In mice, retinoic acid upregulated Defa1, Defa5, Defa21, and regenerating islet-derived protein 3-γ (Reg3g) in intestinal organoids [48], Camp in primary preadipocytes [55], along with Reg3b and Reg3g in lymphocytes [172]. Retinol and retinaldehyde significantly increased Defb3 expression in mouse skin, suggesting that topical retinols may be a potential treatment of cutaneous infections via increased expression of HDPs [56]. The expression of porcine cathelicidin PR-39 was enhanced in bone marrow cells by retinoic acid [173]. However, retinoic acid failed to induce HDP expression in ovine respiratory epithelial cells [174].

Niacin, also known as vitamin B-3, was found to elevate HDP gene expression in porcine IPEC-J2 cells as well as throughout the intestinal tract of piglets [58,59]. Notably, supplementation of niacin alleviated the disease severity of porcine deltacoronavirus [58] as well as enterotoxigenic E. coli K88 in weaned piglets [59]. Niacin appeared to induce porcine HDP gene expression through epigenetic modifications. Improved HDP mRNA concentrations coincided with increased expression concentrations of sirtuin (SIRT) 1 and reduced HDAC7 in the intestine of piglets in response to niacin supplementation [59]. Niacin enhanced phosphorylation of histone H3 at Ser10 (H3S10p) in the ileum as well as acetylation of lysine 9 on histone 3 (H3K9ac) and H3K27ac in the colon of piglets challenged with ETEC K88 [59].

Nicotinamide, an amide form of niacin, improved the expression of CAMP in human neutrophils but not in monocytes [57]. Increased Camp protein concentrations were also detected in bone marrow mononuclear cells of mice supplemented with nicotinamide, while the treatment enhanced S. aureus killing by ≤1000-fold in a systemic murine infection model [57]. Vitamin C, also known as ascorbic acid, increased DEFB1 but not CAMP gene expression in human keratinocytes, [60]. Vitamin C was similarly found to increase DEFB mRNA concentrations in the digestive gland of abalone [61].

Amino acids

Essential, branched-chain amino acids, including isoleucine, leucine, and valine, are each capable of upregulating HDP expression. Isoleucine increased DEFBs across multiple animal species, including humans [62,63], mice [63], cattle [64], pigs [65,175], and catfish [67] (Table 1 [[15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157]]). For example, isoleucine supplementation increased Defb3 and Defb4 expression, which led to a decrease in intestinal bacillary loads and tissue damage after mice were inoculated with a multidrug resistant M. tuberculosis H37Rv [63]. Leucine increased Defa1 in mouse Paneth cells [23], 4 DEFBs in the jejunum and ileum of piglets [66], as well as DEFB transcription in the intestine of hybrid catfish [68]. Valine supplementation improved intestinal DEFB mRNA concentrations in piglets [66] and upregulated DEFB1 and CATH7 in cultured mammary epithelial cells of goats [176].

Tryptophan and threonine are essential amino acids to mammals that have also been shown to upregulate HDP production. Tryptophan improved both mRNA and protein concentrations of Defb2 in the jejunal and ileal mucosa of rats [177], as well as Reg3g and Reg3b mRNA concentrations in mouse ileal mucosa [69]. Tryptophan also increased the expression of multiple HDP genes in porcine IPEC-J2 cells [70]. Furthermore, diets with adequate tryptophan (0.21%, 0.28%, or 0.35%) elevated PBD2 protein concentration across the small intestine of piglets compared with a 0.14% tryptophan diet [71]. L-threonine similarly induced the transcription of DEFBs in porcine IPEC-J2 cells [72]. Supplementation with threonine compared with a threonine-deficient diet enhanced mRNA concentrations of hepcidin antimicrobial peptide (HAMP), liver-enriched antimicrobial peptide (LEAP) 2, and DEFB1 in the head kidney and spleen of grass carp [73].

Furthermore, arginine upregulated DEFB1 in human HCT-116 colonic epithelial cells [62,74]. Dietary arginine enhanced Defa29 and Reg3g expression in mouse Paneth cells and decreased E. coli colonization in the jejunum of challenged mice [74]. In porcine IPEC-J2 cells, L-arginine triggered DEFB transcription and could ameliorate LPS-induced inflammation [178]. Glutamine is a non-essential amino acid capable of HDP induction in mice. Defa4 mRNA was increased in the small intestine of mice supplemented with glutamine [75]. Similarly, glutamine augmented Defa29 and Reg3g mRNA expression and decreased E. coli colonization in mice [74].

Isoleucine, tryptophan, and threonine involve SIRT1 to initiate a signaling cascade that enhances HDP gene expression; however, whether SIRT1 is activated or inhibited varies among individual amino acids. In porcine intestinal epithelial cells and the intestine of hybrid catfish, isoleucine activated a SIRT1/ERK/90RSK signaling pathway to upregulate several HDP genes [66,67]. However, threonine suppressed SIRT1 expression in porcine intestinal epithelial cells, which enhanced acetylation of p65, promoted translocation of p65 into the nucleus, and activated NF-κB [72]. Tryptophan, on the contrary, had no direct effect on SIRT1 expression but suppressed LPS-induced SIRT1 expression in mouse ileal mucosa and porcine intestinal epithelial cells [69]. The mammalian target of rapamycin pathway is involved in induction of DEFBs by tryptophan [177] and arginine [178].

Sugars

Lactose, a disaccharide sugar, was shown to induce CAMP transcription in a dose-dependent and time-dependent manner in human HT-29 and T84 colonic epithelial cells and THP-1 monocytes/macrophages [76] (Table 1 [[15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157]]). In fact, several other monosaccharide and disaccharide sugars such as glucose, galactose, trehalose, and maltose also showed varied potency in inducing CAMP gene expression [76]. Glucose supplementation upregulated DEFB1 and CAMP gene expression in human keratinocytes, leading to greater antimicrobial activity against both Listeria monocytogenes and S. aureus [60]. Interestingly, high glucose induced DEFB1 expression in human kidney and colon cells [79]. Similarly, Defb1 was also upregulated in the kidneys of hyperglycemic rats [80]. However, the expression of human CAMP, DEFB3, and DEFB4 were downregulated by glucose [179,180]. Multiple sugars, such as lactose, glucose, galactose, trehalose, maltose, sucrose, and fructose, increased HDP gene expression in chicken cells [77]. In pigs, lactose induced several DEFB genes in the jejunal mucosa and mitigated the negative effect of Rotavirus on animal growth [78]. Lactose-mediated HDP induction involves the MAPK pathway and histone acetylation. In HT-29 colonic epithelial cells, an inhibition of p38 MAPK and JNK reduced CAMP induction by lactose [76], and histone H4 acetylation was increased in chicken HD11 macrophage cells in response to lactose [77]. Additional studies are needed to clarify the mechanisms by which sugars upregulate HDP.

Minerals

Zinc exerts a plethora of benefits for mounting an effective immune response to infectious agents [181]. Among them is zinc’s ability to induce HDP synthesis. Zinc was found to induce CAMP in human Caco-2 colonic epithelial cells [81] and DEFB4 in LPS-induced inflammatory skin explants [82] (Table 1 [[15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157]]). Zinc also upregulated DEFB concentrations in porcine intestinal epithelial cells [65]. On the contrary, zinc deficiency was accompanied by a decrease in Paneth cell DEFA synthesis in both humans [182] and mice [183]. Calcium is capable of inducing multiple DEFB gene transcription in human keratinocytes [83,84], while DEFB4 expression was reduced when calcium was chelated [184]. Chelation of calcium prevented cathelicidin-mediated killing of human Jurkat T leukemia cells [185] and inhibited DEFB-mediated fungicidal activity against Candida albicans [186].

Bile acids

Several bile acids have been reported to upregulate HDP gene expression. A primary bile acid, chenodeoxycholic acid, and a secondary bile acid, ursodeoxycholic acid, induced CAMP transcription in human biliary epithelial cells [86] (Table 1 [[15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157]]). Another secondary bile acid, lithocholic acid (LCA), upregulated CAMP in human HT-29 colonic epithelial cells [16] and primary keratinocytes [85] but not in human Caco-2 colonic epithelial cells [85]. In mouse 3T3-L1 adipocytes, α-tauromuricholic acid and taurohyodeoxycholic acid, increased Camp mRNA expression, but cholic acid, deoxycholic acid, and taurodeoxycholic acid had no effect [87]. Two nuclear receptors, farnesoid X receptor and VDR, are involved in the upregulation of CAMP by bile acids (Figure 2). Although chenodeoxycholic acid induced CAMP through farnesoid X receptor, ursodeoxycholic acid activated VDR [187]. LCA likewise signaled through VDR to improve CAMP gene expression [16,85]. Moreover, MEK-ERK signaling was involved in CAMP gene regulation by LCA in primary human keratinocytes [85], while VDR recruited PU.1 to the CAMP gene promoter in HT-29 colon epithelial cells [16].

Phytochemicals

Polyphenols are a diverse group of naturally occurring compounds found in plants with anti-inflammatory, antioxidant, and anticancer properties [188]. Several classes of polyphenols, such as flavonoids, stilbenes, and phenolic acids, are capable of inducing HDP synthesis [189] (Table 1). For example, epigallocatechin gallate (EGCG), a flavonoid found in green tea, enhanced DEFB synthesis in humans [88,89], pigs [90], and chickens [91]. Quercetin is another flavonoid with an ability to improve HDP expression in rats [92], chickens [91,93], and zebrafish [94]. Saponarin (a flavone), genistein (an isoflavone), and apigenin (a trihydroxyflavone) enhanced CAMP transcription in human keratinocytes [[95], [96], [97]]. Additionally, xanthohumol (a prenylated flavonoid), calycosin (an isoflavone), datiscetin (a tetrahydroxyflavone), and isoliquiritigenin (a chalcone flavonoid) have been found to induce multiple DEFB genes in pigs [98], chickens [99], and humans [95,100], respectively. Resveratrol, a stilbene in grapes, stimulated HDP gene expression in humans, mice, rats, and chickens [91,92,[101], [102], [103], [104]]. Similarly, polydatin and pterostilbene, 2 resveratrol derivatives, were shown to increase HDP production in human keratinocytes [105] and monocytes [103] as well as in porcine macrophages [98]. Isorhapontigenin, a stilbenoid, augmented the expression concentrations of several DEFBs in porcine intestinal epithelial cells [98]. Phenolic acids, such as ellagic acid, caffeic acid, and anacardic acid, increased the DEFB expression in humans [106], mice [107], and chickens [91]. Curcumin, belonging to the curcuminoid group of polyphenols, stimulated CAMP expression in human monocytes, colonic epithelial cells, and keratinocytes [108] and enhanced HAMP, LEAP2, and DEFB mRNA concentrations in grass carp [109].

A few nonpolyphenol phytochemicals have also been found to upregulate HDP synthesis. For instance, forskolin (FSK), a diterpenoid produced by the Indian Coleus plant, was shown to enhance the expression of CAMP in human HT-29 epithelial cells [110], but suppress CAMP and DEFB1 concentrations in butyrate-differentiated HT-29 cells [161]. Chicken macrophage cells treated with FSK increased avian β-defensin 9 (AvBD9) transcription in chicken macrophage cells as well as in the crop of orally supplemented chickens [26]. Two diterpenoids, andrographolide and oridonin, were found to induce DEFB3 expression in human colonic epithelial cells [100]. The supernatant of cells treated with andrographolide and isoliquiritigenin limited the growth of 4 pathogenic bacteria [100]. A number of natural products and phytochemicals in particular were recently identified with the HDP-inducing activity in chicken and porcine cells through high throughput screening [98,99]. For instance, 1 plant alkaloids, tetrandrine and sanguinarine, were each capable of inducing chicken HDP gene expression [99], while deoxyshikonin, a plant naphthoquinone, increased PBD expression [98].

Many phytochemicals upregulate HDP synthesis through MAPK signaling pathways. For example, EGCG induced DEFB1, DEFB3, and DEFB4 via MAPK p38/ERK/JNK pathways in human bronchial or gingival epithelial cells [88,89] and required p38 activation for PBD2 induction in porcine intestinal epithelium [90]. Andrographolide, oridonin, and isoliquiritigenin activated MAPK pathways downstream of the epidermal growth factor (EGF) receptor and recruited c-Fos, c-Jun, and Elk1 or cMyc to the DEFB3 promoter in human colon epithelial cells [100]. Although andrographolide upregulated DEFB3 by EGFR/ERK/JNK, oridonin and isoliquiritigenin instead worked through an EGFR/ERK/p38 signaling pathway [100]. Sulforaphane required VDR and ERK1/2 but not p38 to increase DEFB4 transcription in human intestinal epithelium [17]. In chicken macrophage cells, inhibitors of p38 or JNK nearly abolished FSK-induced AvBD9 [26]. MAP kinases are required for the upregulation of HDP by many phytochemicals, albeit the specific signaling cascade varies by treatment.

A NF-κB pathway was activated by resveratrol, genistein, or sulforaphane for HDP upregulation. Resveratrol-induced CAMP in human keratinocytes required the spingosine-1-phosphate (S1P) signaling, followed by transactivation of NF-κB and transcription factor C/EPBα [102]. A similar ER-β→S1P→NF-κB →C/EPBα mechanism was found for CAMP induction in keratinocytes treated with genistein [97]. Sulforaphane incubated with a NF-κB inhibitor reduced DEFB4 transcription in human intestinal epithelium [17]. NF-κB was also required for quercetin-induced AvBD9 induction in chicken monocytes [91]. However, dietary quercetin supplementation downregulated NF-κB mRNA expression in the chicken ileum although multiple AvBD genes were enhanced [93]. The involvement of NF-κB in HDP regulation by phytochemicals should be confirmed in vivo for additional species.

Interestingly, resveratrol, EGCG, quercetin, anacardic acid, and garcinol are natural cyclooxygenase (COX)-2 inhibitors that are able to upregulate HDPs in chicken monocytes [91]. Soponarin and apigenin were also found to inhibit COX-2 in human keratinocytes stimulated with inflammatory cytokines [95], mouse macrophages, and rat basophils [96]. Although inhibition of COX-2 signaling has previously been linked to HDP expression [190], its involvement in HDP regulation after treatment with these polyphenols remains to be studied.

Nuclear factor erythroid 2-related factor 2 (Nrf2) facilitates HDP expression in the liver in response to phytochemical treatment. Quercetin treatment increased binding of Nrf2 to an antioxidant response element at the HAMP promoter in parallel to enhanced HAMP transcription in human hepatocytes [92]. Curcumin likewise upregulated Nrf2 mRNA concentrations while increasing HAMP, LEAP2, and DEFB in grass carp liver [109].

FSK elevates intracellular cAMP concentrations, and binding of CREB to the human cathelicidin promoter promoted active gene transcription [110]. However, cAMP inhibited by 2',3'-dideoxyadenosine improved quercetin-induced AvBD9 in chicken monocytes [91]. The role of cAMP in HDP regulation needs to be clarified for different species and HDP genes.

Epigenetic modulators

Epigenetic modifications, such as acetylation of histones and methylation of histones and DNA, play an essential role in regulating chromatin accessibility and gene expression [191]. Histone acetylation is facilitated by histone acetyltransferases to favor a more relaxed chromatin structure, whereas the removal of acetyl groups by HDACs favors a more condensed chromatin configuration [191]. Histones and DNA can also be methylated by DNA methyltransferases (DNMT) and histone methyltransferases (HMT), respectively, to affect gene transcription [191]. HDAC inhibitors have been demonstrated to be among the most potent inducers of HDPs in several high throughput screenings [99,114,121,124,126,192]. Members of all 4 major classes of HDAC inhibitors, including benzamides, hydroxamates, cyclic peptides, and SCFAs, have been shown to be HDP inducers. For example, trichostatin A, a hydroxamate HDCA inhibitor, induced mRNA expression of HDPs in humans [15,18], pigs [114], chickens [99], and cattle [115] (Table 1). Other hydroxamte HDAC inhibitors, such as vorinostat also known as suberoylanilide hydroxamic acid, induced the mRNA expression of DEFA1, DEFA5, DEFA6, and DEFB4 in human monocytic cells infected with Leishmania donovani, contributing to increased antiparasitic activity [117]. Vorinostat also enhanced the expression of several HDP genes in human intestinal epithelium [112,118] and hepatocytes [119], chicken macrophages, [120,126] and porcine intestinal epithelial cells and lung alveolar macrophages [114].

However, among all HDAC inhibitors, benzamides appear to be the most potent HDP inducers in humans, pigs, and chickens as revealed in several recent high throughput assays [114,121,124,126,192]. For example, entinostat, a benzamide HDAC inhibitor, potently enhanced DEFB1 and CAMP mRNA expression in intestinal epithelial cells [121,122] and protected rabbits from experimental cholera [123]. Its analogous compounds, known as aroylated phenylenediamines, had similar effects in human bronchial epithelial cells, associated with a significant reduction in the intracellular invasion of Pseudomonas aeruginosa [125]. Entinostat also similarly induced HDP gene expression in chicken jejunal explants, and an oral inoculation of entinostat led to an increased expression of multiple HDP genes in the crop and jejunum of broiler chicks [124]. Mocetinostat, an entinostat analog, potently increased AvBD9 mRNA concentrations in chicken jejunal explants [126]. Polyphenols, such as sulforaphane, curcumin, and EGCG, are known natural HDAC inhibitors [193] with an HDP-inducing activity [17,89,108].

In addition to HDAC inhibitors, inhibitors of DNMT and HMT are HDP inducers. For instance, 5-azacytidine, a well-known DNMT inhibitor, increased CAMP and DEFB concentrations in gingival epithelial cells [111], oral carcinoma cells [127,128], keratinocytes [113], and chondrocytes [129]. Additionally, 5-azacytidine stimulated HDP expression in bovine mammary epithelial cells [115], chicken macrophage cells [120], the larvae of silkworm [130], as well as in the caput, cauda, and testis of the male rats [116]. Polyphenols such as EGCG, quercetin, and genistein, known for their DNMT inhibitory properties [194], also possess the ability to induce HDP synthesis as discussed in greater detail in an earlier section. Similarly, inhibitors of HMT, such as BIX01294 and UNC1999, have been shown to promote the expression of multiple HDPs in chicken macrophages [120].

Inhibition of HDACs, DNMTs, and HMTs may facilitate chromatin relaxation and promote gene transcription. Several HDAC inhibitors have demonstrated the capacity to promote histone acetylation at HDP promoter regions, accompanied by increased HDP transcription [18,112,117,195]. HDAC inhibition may also activate transcription factors such as NF-κB to turn on the transcription of HDPs such as DEFB4 owing to the presence of multiple NF-κB binding sites in the promoter region [118] (Figure 3). Consistently, trichostatin A increased activation and translocation of NF-κB through acetylation of p65 and phosphorylation of the IKK complex, ultimately leading to an increased binding of NF-κB to the DEFB4 promoter in human colonic epithelial cells [112]. Entinostat and its structural analog, HO53, promoted STAT3 activation leading to increased HIF1α expression and binding of HIF-1α to the CAMP promoter [122,125]. Similarly, RGFP966, an HDAC3 inhibitor, increased acetylation of STAT3, C/EBPα, and HIF-1α in human liver cells, enhancing the affinity of these transcription factors to the LEAP1 promoter [119].FIGURE 3 Epigenetic mechanisms of HDP gene induction. See text for details. Ac, acetyl group; C/EBPα, CCAAT enhancer binding protein α; DNMTi, DNA methyltransferase inhibitor; HDACi, histone deacetylase inhibitor; HIF1α, hypoxia-inducible factor-1α; HMTi, histone methyltransferase inhibitor; IKK, Iκ B kinase; P, phosphate group; Me, methyl group; TSA, trichostatin A; p50/p65, NF-κB proteins p50 and p65 heterodimer; STAT, signal transducer and activator of transcription.

FIGURE 3

DNMT inhibitors, such as AZA, reduced DNA methylation at DEFB1 [113] and CAMP [128,129] promoter regions, resulting in an increase in their transcription. Although the mechanism to support HMT inhibitors, BIX01294 and UNC1999, has not been well studied, a strong correlation has been found between histone demethylase, JMJD3, and expression of DEFB3, S100A7, S100A8, and CAMP in human keratinocytes [196]. Moreover, JMJD3 knockdown led to significantly increased histone methylation concentrations and reduced mRNA expression of these HDPs, highlighting the importance of histone methylation in shaping HDP gene expression patterns [196].

Probiotics

Probiotics are beneficial microbes that promote intestinal health through a myriad of mechanisms [197]. A variety of lactic acid bacteria have been found to induce HDP expression. For example, several Lactobacillus species induced HDP in human intestinal epithelia [[131], [132], [133], [134],136], gingival epithelia [135,137], vaginal epithelia [113,138], cervical epithelia [139], and epidermal cells [140] (Table 1). Oral supplementation of Lactobacillus delbruckii subsp. bulgaricus 8481 decreased IL-8 and increased DEFB4 in elderly patients [141]. In infants, Bifidobacterium animalis subsp. lactis BB-12 elevated both CAMP and DEFB4 protein concentrations [142]. E. coli Nissle 1917 were found to enhance DEFB4 expression in human intestinal epithelial cells [143,198].

Probiotics also induced HDP expression in rodents, pigs, chickens, cattle, and sheep. For instance, lactic acid bacteria were found to enhance HDP production and alleviate colitis [144], vancomycin-resistant enterococcus infection [199], and cirrhosis in mice [145]. In pigs, Lactobacillus reuteri I5007, Lactobacillus amylovorus SLZX20, and Lactobacillus plantarum ZLP001 increased the mRNA expression of multiple DEFBs in porcine intestinal epithelial cell lines [147,149,200], while L. plantarum counteracted intestinal barrier dysfunction induced by enterotoxigenic E. coli [148]. Treatment of intestinal cells with Bacillus subtilis CP9 enhanced PG1 transcription, but not PBD3, while having anti-ETEC properties [150]. Co-administration of Lactobacillus salivarius B1 and B. subtilis RJGP16 significantly induced the expression of PBD2 in the duodenum of neonatal piglets [151]. Likewise, both L. reuteri D8 and Lactobacillus rhamnosus Gorbach-Goldin (GG) increased body weight gain and decreased the incidence of diarrhea by upregulating HDPs in the jejunum of piglets [152,201].

In chickens, modulation of intestinal HDPs by L. reuteri is gene specific: AvBD1 and CATH3 mRNA expressions were increased, while CATH2 and AvBD10 were decreased, with no change observed with AvBD2 or AvBD12 [153,202]. In bovine mammary epithelial cells, Lactobacillus casei BL23 sustained the expression of DEFs during infection with S. aureus [154]. Furthermore, DEFB1 was increased in colon mucosa from dairy cows supplemented with live Saccharomyces cerevisiae CNCM I-1077 [155]. S. cerevisiae similarly upregulated SBD1 in ovine ruminal epithelial cells [203]. However, not all probiotics have the capacity to induce HDP synthesis. For instance, Bifidobacterium breve M16V did not affect the expression of DEFB1, DEFB4, or CAMP in preterm human infants [204], and 3 of 7 L. casei strains tested failed to upregulated Reg3b or a DEFA in the ileum of mice [146].

Probiotics such as Lactobacillus [133,147] or S. cerevisiae [203] triggered TLR2 along with MAPK and/or NF-κB signaling pathways to induce HDP gene expression in human, porcine, and ovine cells (Figure 4). L. rhamnosus GG and L. plantarum increased VDR protein expression in both mouse and human intestinal epithelial cells and induce CAMP gene expression through VDR [205]. On the contrary, L. gasseri, but not L. reuteri, induced DEFB1 gene expression associated with increased concentrations of histone H3 acetylation, H3K4me3, and H2A.Z in the proximal promoter region of the DEFB1 gene [113]. E. coli Nissle 1917, Pediococcus pentosaceus, Lactobacillus fermentum, and Lactobacillus acidophilus required NF-κB signaling in addition to AP-1 activation to induce DEFB4 [143,198]. An increase in HDP was paralleled by expression of nucleotide-binding oligomerization domain (NOD1/2) in cells treated with L. rhamnosus GG., B. longum spp. Infantis S12, or BI 5764 [136,144]. However, L. reuteri I5007 enhanced HDPs though upregulation of peroxisome proliferator-activated receptor-γ and GPR41 in porcine epithelial cells [200], while L. casei BL23 had no effect on NOD2 nor NF-κB [154]. These discrepancies may be due to differences in probiotic-host interaction or variation in signaling mechanisms between host species. Regardless, the escalating interest in the use of probiotics to promote host health warrants continued research into the mechanisms behind probiotic-induced HDP expression.FIGURE 4 Molecular mechanisms of HDP gene expression by probiotics. See text for details. Ac, acetyl group; AP1, activator protein-1; HDP, host defense peptide; MAPK, mitogen-activated protein kinases; NF-κB, nuclear factor-kappa B; TLR, toll-like receptor, VDR, vitamin D receptor.

FIGURE 4

Prebiotics

Supplementation of inulin to a Western-style diet increased the expression of multiple Paneth cell DEFAs and DEFB1 as well as tight junction proteins in the intestinal tissues of mice, resulting in improved intestinal barrier integrity and reduced endotoxemia [24] (Table 1). Similarly, long-chain, but not short-chain, inulin-type fructans delayed the onset of type 1 diabetes by promoting gut health, including a significant increase in Defb1 and Camp in the colon of mice [156]. Additionally, oral administration of polysaccharides extracted from Dendrobium huoshanense, a medicinal plant, enhanced DEFB production and barrier function of the intestinal tract of mice [157]. The HDP-inducing activity of other prebiotics remains to be studied.

Synergistic induction of HDP synthesis by different classes of dietary compounds

Several different classes of dietary compounds have been found to synergize with each other to potentiate HDP synthesis (Table 2) [16,26,35,36,76,77,91,99,100,103,105,[120], [121], [122],206,207]. For example, vitamin D-3 is synergistic with butyrate or PBA in CAMP synthesis in bronchial epithelial cells and macrophages, showing a bacteriostatic effect against M. tuberculosis [36,206]. The combination of vitamin D-3 and PBA was also shown to induce HDPs in human dendritic cells, leading to effective killing of S. aureus [207]. Vitamin D-3 further synergized with entinostat, resveratrol, or pterostilbene to induce CAMP synthesis in human colon cells, monocytes, or keratinocytes [103,121,122]. Synergy in augmenting CAMP expression was also observed when vitamin D-3 was combined with calcium in normal and cystic fibrosis bronchial epithelial cells [208].TABLE 2 Synergistic induction of HDP synthesis by combinations of different classes of dietary compounds

TABLE 2Compounds	Cells or tissues	HDPs	References	
Butyrate + lithocholic acid	Human HT-29	CAMP	[16]	
Butyrate + forskolin	Chicken HD11, HTC, jejunal explants	AvBD9	[26]	
Butyrate + propionate + acetate	Chicken HD11 macrophages	AvBD9	[35]	
Butyrate/PBA + lactose	Human HT-29	CAMP	[76]	
Butyrate + galactose/trehalose/lactose	Chicken HD11 macrophages	AvBD9, CATHB1	[77]	
Butyrate + COX-2 inhibitors	Chicken HTC, PBMCs	AvBD9	[91]	
Butyrate + wortmannin/tetrandrine/datiscetin	Chicken HTC, chicken monocytes	AvBD9	[99]	
Vitamin D-3 + PBA	Human VA10, MDM, PBMCs	CAMP	[36,206,207]	
Vitamin D-3 + resveratrol/pterostilbene	Human U937, HaCaT	CAMP	[103]	
Vitamin D-3 + entinostat	Human HT-29	CAMP	[121,122]	
Vitamin D-3 + calcium	Human NHBE	CAMP	[208]	
Andrographolide + isoliquiritigenin	Human Caco-2	DEFB3	[100]	
Polydatin + resveratrol	Human HaCaT	DEFB4	[105]	
HDACi + HMTi/DNMTi	Chicken HTC, HD11 macrophages	AvBD9	[120]	
Abbreviations: AvBD, avian β-defensin; CAMP, cathelicidin; CATH, chicken cathelicidin; COX, cyclooxygenase; DEF, defensin; DNMTi, DNA methyltransferase inhibitor; HDACi, histone deacetylase inhibitor; HDP, host defense peptide; HMTi, histone methyltransferase inhibitor; PBA, phenylbutyrate.

In addition to vitamin D-3, butyrate synergizes with several other classes of dietary compounds to enhance HDP synthesis. When combined with lactose, butyrate or 4-PBA showed a synergistic effect on human CAMP expression [76]. Similarly, butyrate synergized with other sugars, such as galactose or trehalose, to upregulate HDP expression in chicken macrophages [77]. Administration of butyrate and FSK showed a synergistic increase in AvBD9 in the crop and jejunum of chickens [26]. An even higher magnitude of HDP gene induction and protection against necrotic enteritis was observed with the combination of butyrate, lactose, and FSK over any of the 2-compound combinations in chickens [209]. Butyrate in combination with wortmannin, a naturally occurring fungal metabolite and a specific phosphoinositide 3-kinase inhibitor, synergistically increased HDP expression in chickens [99]. Additionally, butyrate synergized with tetrandrine or datiscetin in chicken HDP gene induction [99]. Several polyphenols and COX-2 inhibitors, namely quercetin, resveratrol, anacardic acid, EGCG, and garcinol had a strong synergy with butyrate in HDP transcription in chicken cells [91]. Additionally, butyrate synergized with other SCFAs such as acetate and propionate in enhancing chicken HDP expression both in vitro and in vivo [35].

Furthermore, polydatin, a natural precursor to resveratrol, synergistically increased DEFB4 production in human keratinocytes when combined with resveratrol [105]. Andrographolide and isoliquiritigenin cooperated to enhance DEFB3 expression and antibacterial activity of human colonic epithelial cells [100]. Different classes of epigenetic compounds also appear to act in a corporative manner in increasing HDP gene expression. For instance, an HDAC inhibitor paired with an inhibitor of either an HMT or a DNMT led to a drastic synergy in the transcription of multiple HDP genes in chicken macrophages [120]. Additionally, probiotics such as E. coli Nissle 1917 synergizes with HDCA inhibitors to enhance DEFB4 expression in human intestinal cell lines, but not in human colonic biopsies [118].

The mechanism for synergy between HDP inducers remains elusive. HDAC inhibitors including butyrate increase histone acetylation in favor of active gene transcription [30], so a proposed mechanism for synergy with butyrate involved additional enrichment of histone acetylation. Butyrate and lactose treatment led to the hyperacetylation of H4 preceding a synergistic response in chicken HDP gene induction [77]. However, no additional histone acetylation was observed for butyrate and quercetin in relation to their synergy in chicken HDP transcription [91]. Changes in histone acetylation are insufficient to describe the synergy observed between butyrate and a secondary HDP inducer.

Other studies looked at the signaling pathways activated by individual compounds compared with compound combinations. A similar involvement of p38 MAPK, JNK, NF-κB, and cAMP signaling pathways was observed in response to butyrate and lactose as for butyrate alone [77]. Likewise, the signaling pathways activated by lactose and PBA for synergistic induction of CAMP coincided with those found for the individual treatments [210].

The mechanism appears to be due to the cooperation between epigenetic modulation and regulation of signaling pathways and/or specific transcription factors as opposed to synergy in boosting any individual pathway. For example, induction of CAMP transcription involved cooperation among VDR, C/EBPα, PU.1, and chromatin remodeling [171]. On the contrary, inhibition of ERK1/2 and MAPK-p38 by resveratrol was found to contribute to the synergy with vitamin D-3 in augmenting CAMP gene expression [103]. The synergistic effect of andrographolide and isoliquiritigenin on DEFB3 expression was supported by higher phosphorylation of H3S10 and recruitment of transcription factors Fos and ELK1 than use of either molecule alone [100]. A plausible mechanism for synergy between HDP inducers could be due to increased transcription factor binding when 1 or both modulators can also induce epigenetic changes in favor of an accessible HDP gene promoter.

Conclusions and Future Prospects

Dietary modulation of endogenous HDP synthesis has potential to be developed as an alternative approach to antimicrobial therapy. Several HDP inducers, such as butyrate, 4-PBA, and vitamin D-3, have demonstrated protective efficacy against infectious diseases across multiple animal species. It is noted that nutritional modulation of endogenous HDP synthesis is unlikely to drive antimicrobial resistance, as these HDP-inducing dietary factors act on the host without exerting direct antimicrobial activity. Additionally, unlike other immune boosters that often nonspecifically trigger inflammation, many of the HDP-inducing compounds stimulate the synthesis of HDPs without eliciting a proinflammatory response while some even have anti-inflammatory effects [31,69,100]. This is beneficial, as inflammation can lead to detrimental effects on the host, such as tissue damage. However, additional human and animal trials are warranted to realize the clinical potential of HDP inducers as novel host-directed antimicrobials.

It is noted that different classes of dietary compounds have a strong capacity to induce HDPs in multiple cell types and animal species, although cell-specific and species-specific HDP induction is evident. Importantly, many compounds show a synergy in promoting HDP synthesis when combined. Mechanisms of dietary compound-mediated HDP induction are being investigated and a detailed understanding of the molecular mechanisms may allow further HDP-inducing efficiency. Current evidence indicates the involvement of histone acetylation as well as MAPK, NF-κB, VDR, cAMP, and COX-2 signaling pathways. Transcription factors such as AP-1, CREB, STAT3, and sphingosine-1-phosphate have also been implicated in nutritional regulation of HDPs. Further investigation may yield dietary compounds or their combinations as promising candidates as effective alternatives to antibiotics for both human and animal applications.

Author contributions

The authors’ responsibilities were as follows – GZ: conceived the study; MW, IT, AB, GZ: drafted the manuscript; IT, MW: contributed to visualization; GZ: edited the manuscript and has primary responsibility for final content; and all authors: read and approved the final manuscript.

Conflict of interest

The authors report no conflicts of interest.

Funding

This research was supported by the USDA National Institute of Food and Agriculture grants (2020-67016-31619 and 2023-67015-39095), the Ralph F. and Leila W. Boulware Endowment Fund, and Oklahoma Agricultural Experiment Station Project H-3112. MW was supported by a USDA National Institute of Food and Agriculture Predoctoral Fellowship grant (2021-67034-35184). However, the funders had no role in the design of the study, the collection or interpretation of data, the writing of the manuscript, or the decision to publish the results.

Acknowledgments

We apologize for not being able to include all references owing to space constraints. All figures were created with BioRender.
==== Refs
References

1 Schrader S.M. Vaubourgeix J. Nathan C. Biology of antimicrobial resistance and approaches to combat it Sci. Transl. Med. 12 549 2020 eaaz6992 10.1126/scitranslmed.aaz6992
2 Ghosh C. Sarkar P. Issa R. Haldar J. Alternatives to conventional antibiotics in the era of antimicrobial resistance Trends Microbiol 27 4 2019 323 338 10.1016/j.tim.2018.12.010 30683453
3 Christaki E. Marcou M. Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence J. Mol. Evol. 88 1 2020 26 40 10.1007/s00239-019-09914-3 31659373
4 Darby E.M. Trampari E. Siasat P. Gaya M.S. Alav I. Webber M.A. Molecular mechanisms of antibiotic resistance revisited Nat. Rev. Microbiol. 21 5 2023 280 295 10.1038/s41579-022-00820-y 36411397
5 Watkins R.R. Bonomo R.A. Overview: the ongoing threat of antimicrobial resistance Infect. Dis. Clin. North. Am. 34 4 2020 649 658 10.1016/j.idc.2020.04.002 33011053
6 Vidovic N. Vidovic S. Antimicrobial resistance and food animals: influence of livestock environment on the emergence and dissemination of antimicrobial resistance Antibiotics (Basel) 9 2 2020 52 10.3390/antibiotics9020052 32023977
7 McEwen S.A. Collignon P.J. Antimicrobial resistance: a one health perspective Microbiol. Spectr. 6 2 2018 10.1128/microbiolspec.ARBA-0009-2017
8 Bergman P. Raqib R. Rekha R.S. Agerberth B. Gudmundsson G.H. Host directed therapy against infection by boosting innate immunity Front. Immunol. 11 2020 1209 10.3389/fimmu.2020.01209 32595649
9 Wu J. Ma N. Johnston L.J. Ma X. Dietary nutrients mediate intestinal host defense peptide expression Adv. Nutr. 11 1 2020 92 102 10.1093/advances/nmz057 31204774
10 Magana M. Pushpanathan M. Santos A.L. Leanse L. Fernandez M. Ioannidis A. The value of antimicrobial peptides in the age of resistance Lancet Infect. Dis. 20 9 2020 e216 e230 10.1016/S1473-3099(20)30327-3 32653070
11 Lazzaro B.P. Zasloff M. Rolff J. Antimicrobial peptides: application informed by evolution Science 368 6490 2020 10.1126/science.aau5480 eaau5480
12 Mookherjee N. Anderson M.A. Haagsman H.P. Davidson D.J. Antimicrobial host defence peptides: functions and clinical potential Nat. Rev. Drug Discov. 19 5 2020 311 332 10.1038/s41573-019-0058-8 32107480
13 Robinson K. Ma X. Liu Y. Qiao S. Hou Y. Zhang G. Dietary modulation of endogenous host defense peptide synthesis as an alternative approach to in-feed antibiotics Anim. Nutr. 4 2 2018 160 169 10.1016/j.aninu.2018.01.003 30140755
14 Koh A. De Vadder F. Kovatcheva-Datchary P. Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites Cell 165 6 2016 1332 1345 10.1016/j.cell.2016.05.041 27259147
15 Schauber J. Svanholm C. Termen S. Iffland K. Menzel T. Scheppach W. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways Gut 52 5 2003 735 741 10.1136/gut.52.5.735 12692061
16 Termén S. Tollin M. Rodriguez E. Sveinsdóttir S.H. Jóhannesson B. Cederlund A. PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells Mol. Immunol. 45 15 2008 3947 3955 10.1016/j.molimm.2008.06.020 18657865
17 Schwab M. Reynders V. Loitsch S. Steinhilber D. Schröder O. Stein J. The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells Immunology 125 2 2008 241 251 10.1111/j.1365-2567.2008.02834.x 18373608
18 Kallsen K. Andresen E. Heine H. Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cells PLoS One 7 11 2012 e50000 10.1371/journal.pone.0050000
19 Kida Y. Shimizu T. Kuwano K. Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1 Mol. Immunol. 43 12 2006 1972 1981 10.1016/j.molimm.2005.11.014 16423398
20 Jiang W. Sunkara L.T. Zeng X. Deng Z. Myers S.M. Zhang G. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs Peptides 50 2013 129 138 10.1016/j.peptides.2013.10.008 24140860
21 Zhang K. Hussain T. Wang J. Li M. Wang W. Ma X. Sodium butyrate abrogates the growth and pathogenesis of Mycobacterium bovis via regulation of cathelicidin (LL37) expression and NF-κB signaling Front. Microbiol. 11 2020 433 10.3389/fmicb.2020.00433 32265874
22 Zhou Z. Yang H. Li H. Li X. Li X. Wu B. Sodium butyrate ameliorates Corynebacterium pseudotuberculosis infection in RAW264.7 macrophages and C57BL/6 mice Microb. Pathog. 131 2019 144 149 10.1016/j.micpath.2019.04.008 30965088
23 Takakuwa A. Nakamura K. Kikuchi M. Sugimoto R. Ohira S. Yokoi Y. Butyric acid and leucine induce α-defensin secretion from small intestinal Paneth cells Nutrients 11 11 2019 2817 31752111
24 Beisner J. Filipe Rosa L. Kaden-Volynets V. Stolzer I. Günther C. Bischoff S.C. Prebiotic inulin and sodium butyrate attenuate obesity-induced intestinal barrier dysfunction by induction of antimicrobial peptides Front. Immunol. 12 2021 678360 10.3389/fimmu.2021.678360
25 Sunkara L.T. Achanta M. Schreiber N.B. Bommineni Y.R. Dai G. Jiang W. Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression PLoS One 6 11 2011 e27225 10.1371/journal.pone.0027225
26 Sunkara L.T. Zeng X. Curtis A.R. Zhang G. Cyclic AMP synergizes with butyrate in promoting beta-defensin 9 expression in chickens Mol. Immunol. 57 2 2014 171 180 10.1016/j.molimm.2013.09.003 24141182
27 Alva-Murillo N. Medina-Estrada I. Báez-Magaña M. Ochoa-Zarzosa A. López-Meza J.E. The activation of the TLR2/p38 pathway by sodium butyrate in bovine mammary epithelial cells is involved in the reduction of Staphylococcus aureus internalization Mol. Immunol. 68 2 Pt B 2015 445 455 10.1016/j.molimm.2015.09.025 26471700
28 Dai H. Wei G. Wang Y. Ma N. Chang G. Shen X. Sodium butyrate promotes lipopolysaccharide-induced innate immune responses by enhancing mitogen-activated protein kinase activation and histone acetylation in bovine mammary epithelial cells J. Dairy Sci. 103 12 2020 11636 11652 10.3168/jds.2020-18198 33010913
29 Zeng X. Sunkara L.T. Jiang W. Bible M. Carter S. Ma X. Induction of porcine host defense peptide gene expression by short-chain fatty acids and their analogs PLoS One 8 8 2013 e72922 10.1371/journal.pone.0072922
30 Xiong H. Guo B. Gan Z. Song D. Lu Z. Yi H. Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition Sci. Rep. 6 2016 27070 10.1038/srep27070
31 Dou X. Han J. Song W. Dong N. Xu X. Zhang W. Sodium butyrate improves porcine host defense peptide expression and relieves the inflammatory response upon Toll-like receptor 2 activation and histone deacetylase inhibition in porcine kidney cells Oncotarget 8 16 2017 26532 26551 10.18632/oncotarget.15714 28460447
32 Dou X. Gao N. Lan J. Han J. Yang Y. Shan A. TLR2/EGFR are two sensors for pBD3 and pEP2C induction by sodium butyrate independent of HDAC inhibition J. Agric. Food Chem. 68 2 2020 512 522 10.1021/acs.jafc.9b06569 31870150
33 Wang S. Zhang C. Yang J. Wang X. Wu K. Zhang B. Sodium butyrate protects the intestinal barrier by modulating intestinal host defense peptide expression and gut microbiota after a challenge with deoxynivalenol in weaned piglets J. Agric. Food Chem. 68 15 2020 4515 4527 10.1021/acs.jafc.0c00791 32208605
34 Nakatsuji T. Kao M.C. Zhang L. Zouboulis C.C. Gallo R.L. Huang C.M. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression J. Invest. Dermatol. 130 4 2010 985 994 10.1038/jid.2009.384 20032992
35 Sunkara L.T. Jiang W. Zhang G. Modulation of antimicrobial host defense peptide gene expression by free fatty acids PLoS One 7 11 2012 e49558 10.1371/journal.pone.0049558
36 Steinmann J. Halldorsson S. Agerberth B. Gudmundsson G.H. Phenylbutyrate induces antimicrobial peptide expression, Antimicrob Agents Chemother. 53 12 2009 5127 5133 10.1128/AAC.00818-09
37 Sarker P. Ahmed S. Tiash S. Rekha R.S. Stromberg R. Andersson J. Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy PLoS One 6 6 2011 e20637 10.1371/journal.pone.0020637
38 Dou X. Han J. Ma Q. Cheng B. Shan A. Gao N. TLR2/4-mediated NF-κB pathway combined with the histone modification regulates β-defensins and interleukins expression by sodium phenyl butyrate in porcine intestinal epithelial cells, Food Nutr Res 62 2018 10.29219/fnr.v62.1493
39 Pineda Molina C. Hussey G.S. Eriksson J. Shulock M.A. Cárdenas Bonilla L.L. Giglio R.M. 4-Hydroxybutyrate promotes endogenous antimicrobial peptide expression in macrophages Tissue Eng. Part A. 25 9–10 2019 693 706 10.1089/ten.TEA.2018.0377 30982430
40 Wang J. Huang N. Xiong J. Wei H. Jiang S. Peng J. Caprylic acid and nonanoic acid upregulate endogenous host defense peptides to enhance intestinal epithelial immunological barrier function via histone deacetylase inhibition Int. Immunopharmacol. 65 2018 303 311 10.1016/j.intimp.2018.10.022 30342347
41 Alva-Murillo N. Ochoa-Zarzosa A. López-Meza J.E. Short chain fatty acids (propionic and hexanoic) decrease Staphylococcus aureus internalization into bovine mammary epithelial cells and modulate antimicrobial peptide expression Vet. Microbiol. 155 2–4 2012 324 331 10.1016/j.vetmic.2011.08.025 21930351
42 Wang T.T. Nestel F.P. Bourdeau V. Nagai Y. Wang Q. Liao J. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression J. Immunol. 173 5 2004 2909 2912 10.4049/jimmunol.173.5.2909 15322146
43 Gombart A.F. Borregaard N. Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3 FASEB J 19 9 2005 1067 1077 10.1096/fj.04-3284com 15985530
44 Liao S. Huang Y. Zhang J. Xiong Q. Chi M. Yang L. Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and Staphylococcus aureus infections Respir. Res. 24 1 2023 175 10.1186/s12931-023-02477-4 37407993
45 Schauber J. Oda Y. Büchau A.S. Yun Q.C. Steinmeyer A. Zügel U. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3 J. Invest. Dermatol. 128 4 2008 816 824 10.1038/sj.jid.5701102 17943182
46 Martineau A.R. Wilkinson K.A. Newton S.M. Floto R.A. Norman A.W. Skolimowska K. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37 J. Immunol. 178 11 2007 7190 7198 10.4049/jimmunol.178.11.7190 17513768
47 Karlsson J. Carlsson G. Larne O. Andersson M. Pütsep K. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia J. Leukoc. Biol. 84 5 2008 1279 1286 10.1189/jlb.0607437 18703682
48 Filipe Rosa L. Petersen P.P. Görtz L.F. Stolzer I. Kaden-Volynets V. Günther C. Vitamin A- and D-deficient diets disrupt intestinal antimicrobial peptide defense involving Wnt and STAT5 signaling pathways in mice Nutrients 15 2 2023 376 36678247
49 Zhang L. Lu L. Li S. Zhang G. Ouyang L. Robinson K. 1,25-Dihydroxyvitamin-D3 induces avian beta-defensin gene expression in chickens PLoS One 11 5 2016 e0154546 10.1371/journal.pone.0154546
50 Téllez-Pérez A.D. Alva-Murillo N. Ochoa-Zarzosa A. López-Meza J.E. Cholecalciferol (vitamin D) differentially regulates antimicrobial peptide expression in bovine mammary epithelial cells: implications during Staphylococcus aureus internalization Vet. Microbiol. 160 1–2 2012 91 98 10.1016/j.vetmic.2012.05.007 22655972
51 Flores-Villalva S. Remot A. Carreras F. Winter N. Gordon S.V. Meade K.G. Vitamin D induced microbicidal activity against Mycobacterium bovis BCG is dependent on the synergistic activity of bovine peripheral blood cell populations Vet. Immunol. Immunopathol. 256 2023 110536 10.1016/j.vetimm.2022.110536
52 Heilborn J.D. Weber G. Grönberg A. Dieterich C. Ståhle M. Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo Exp. Dermatol. 19 4 2010 332 338 10.1111/j.1600-0625.2009.00997.x 19878298
53 Jacobo-Delgado Y.M. Torres-Juarez F. Rodríguez-Carlos A. Santos-Mena A. Enciso-Moreno J.E. Rivas-Santiago C. Retinoic acid induces antimicrobial peptides and cytokines leading to Mycobacterium tuberculosis elimination in airway epithelial cells Peptides 142 2021 170580 10.1016/j.peptides.2021.170580
54 Elloumi H.Z. Holland S.M. Complex regulation of human cathelicidin gene expression: novel splice variants and 5'UTR negative regulatory element Mol. Immunol. 45 1 2008 204 217 10.1016/j.molimm.2007.04.023 17709140
55 Liggins M.C. Li F. Zhang L.J. Dokoshi T. Gallo R.L. Retinoids enhance the expression of cathelicidin antimicrobial peptide during reactive dermal adipogenesis J. Immunol. 203 6 2019 1589 1597 10.4049/jimmunol.1900520 31420464
56 Lee S.E. Lee J.S. Kim M.R. Kim M.Y. Kim S.C. Topical retinoids induce beta-defensin 3 expression in mouse skin Int. J. Dermatol. 49 9 2010 1082 1084 10.1111/j.1365-4632.2009.04260.x 20883279
57 Kyme P. Thoennissen N.H. Tseng C.W. Thoennissen G.B. Wolf A.J. Shimada K. C/EBPepsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice J. Clin. Invest. 122 9 2012 3316 3329 10.1172/JCI62070 22922257
58 Chen Y. Li P. Zhen R. Wang L. Feng J. Xie Y. Effects of niacin on intestinal epithelial barrier, intestinal immunity, and microbial community in weaned piglets challenged by PDCoV Int. Immunopharmacol. 111 2022 109054 10.1016/j.intimp.2022.109054
59 Zhen R. Feng J. He D. Chen Y. Chen T. Cai W. Effects of niacin on resistance to enterotoxigenic Escherichia coli infection in weaned piglets Front. Nutr. 9 2022 865311 10.3389/fnut.2022.865311
60 Cruz Díaz L.A. Flores Miramontes M.G. Chávez Hurtado P. Allen K. Gonzalez Ávila M. Prado Montes de Oca E. Ascorbic acid, ultraviolet C rays, and glucose but not hyperthermia are elicitors of human beta-defensin 1 mRNA in normal keratinocytes BioMed Res. Int. 2015 2015 714580 10.1155/2015/714580
61 Luo K. Li X. Wang L. Rao W. Wu Y. Liu Y. Ascorbic acid regulates the immunity, anti-oxidation and apoptosis in abalone Haliotis discus hannai Ino Antioxidants (Basel) 10 9 2021 1449 10.3390/antiox10091449 34573080
62 Sherman H. Chapnik N. Froy O. Albumin and amino acids upregulate the expression of human beta-defensin 1 Mol. Immunol. 43 10 2006 1617 1623 10.1016/j.molimm.2005.09.013 16263169
63 Rivas-Santiago C.E. Rivas-Santiago B. León D.A. Castañeda-Delgado J. Hernández Pando R. Induction of beta-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis Clin. Exp. Immunol. 164 1 2011 80 89 10.1111/j.1365-2249.2010.04313.x 21235540
64 Fehlbaum P. Rao M. Zasloff M. Anderson G.M. An essential amino acid induces epithelial beta-defensin expression Proc. Natl. Acad. Sci. U.S.A. 97 23 2000 12723 12728 10.1073/pnas.220424597 11058160
65 Mao X. Qi S. Yu B. He J. Yu J. Chen D. Zn(2+) and L-isoleucine induce the expressions of porcine beta-defensins in IPEC-J2 cells Mol. Biol. Rep. 40 2 2013 1547 1552 10.1007/s11033-012-2200-0 23065293
66 Ren M. Zhang S. Liu X. Li S. Mao X. Zeng X. Different lipopolysaccharide branched-chain amino acids modulate porcine intestinal endogenous β-defensin expression through the Sirt1/ERK/90RSK pathway J. Agric. Food Chem. 64 17 2016 3371 3379 10.1021/acs.jafc.6b00968 27083206
67 Zhao Y. Yan M.Y. Jiang Q. Yin L. Zhou X.Q. Feng L. Isoleucine improved growth performance, and intestinal immunological and physical barrier function of hybrid catfish Pelteobagrus vachelli × Leiocassis longirostris Fish Shellfish Immunol 109 2021 20 33 10.1016/j.fsi.2020.09.035 32991991
68 Zhao J. Zhao Y. Liu H. Cao Q. Feng L. Zhang Z. Dietary leucine improves fish intestinal barrier function by increasing humoral immunity, antioxidant capacity, and tight junction Int. J. Mol. Sci. 24 5 2023 4716 36902147
69 Gao N. Yang Y. Liu S. Fang C. Dou X. Zhang L. Gut-derived metabolites from dietary tryptophan supplementation quench intestinal inflammation through the AMPK-SIRT1-autophagy pathway J. Agric. Food Chem. 70 51 2022 16080 16095 10.1021/acs.jafc.2c05381 36521060
70 Gao N. Dou X. Yin T. Yang Y. Yan D. Ma Z. Tryptophan promotes intestinal immune defense through calcium-sensing receptor (CaSR)-dependent metabolic pathways J. Agric. Food Chem. 69 45 2021 13460 13473 10.1021/acs.jafc.1c05820 34748328
71 Rao Z. Li J. Shi B. Zeng Y. Liu Y. Sun Z. Dietary tryptophan levels impact growth performance and intestinal microbial ecology in weaned piglets via tryptophan metabolites and intestinal antimicrobial peptides Animals. (Basel) 11 3 2021 817 10.3390/ani11030817 33799457
72 Wang C. Yang Y. Gao N. Lan J. Dou X. Li J. L-Threonine upregulates the expression of β-defensins by activating the NF-κB signaling pathway and suppressing SIRT1 expression in porcine intestinal epithelial cells Food Funct 12 13 2021 5821 5836 10.1039/D1FO00269D 34047325
73 Dong Y.W. Jiang W.D. Wu P. Liu Y. Kuang S.Y. Tang L. Novel insight into nutritional regulation in enhancement of immune status and mediation of inflammation dynamics integrated study in vivo and in vitro of teleost grass carp (Ctenopharyngodon idella): administration of threonine Front. Immunol. 13 2022 770969 10.3389/fimmu.2022.770969
74 Liu G. Ren W. Fang J. Hu C.A. Guan G. Al-Dhabi N.A. L-glutamine and L-arginine protect against enterotoxigenic Escherichia coli infection via intestinal innate immunity in mice Amino Acids 49 12 2017 1945 1954 10.1007/s00726-017-2410-9 28299479
75 Wang X. Pierre J.F. Heneghan A.F. Busch R.A. Kudsk K.A. Glutamine improves innate immunity and prevents bacterial enteroinvasion during parenteral nutrition JPEN J. Parenter. Enteral. Nutr. 39 6 2015 688 697 10.1177/0148607114535265 24836948
76 Cederlund A. Kai-Larsen Y. Printz G. Yoshio H. Alvelius G. Lagercrantz H. Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasis PLoS One 8 1 2013 e53876 10.1371/journal.pone.0053876
77 Yang Q. Fong L.A. Lyu W. Sunkara L.T. Xiao K. Zhang G. Synergistic induction of chicken antimicrobial host defense peptide gene expression by butyrate and sugars Front. Microbiol. 12 2021 781649 10.3389/fmicb.2021.781649
78 Yu W. Xiao X. Chen D. Yu B. He J. Zheng P. Effect of dietary lactose supplementation on growth performance and intestinal epithelium functions in weaned pigs challenged by Rotavirus Animals 12 18 2022 2336 36139196
79 Barnea M. Madar Z. Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines Biochem. Biophys. Res. Commun. 367 2 2008 452 456 10.1016/j.bbrc.2007.12.158 18178160
80 Page R.A. Malik A.N. Elevated levels of beta defensin-1 mRNA in diabetic kidneys of GK rats Biochem. Biophys. Res. Commun. 310 2 2003 513 521 10.1016/j.bbrc.2003.09.034 14521940
81 Talukder P. Satho T. Irie K. Sharmin T. Hamady D. Nakashima Y. Trace metal zinc stimulates secretion of antimicrobial peptide LL-37 from Caco-2 cells through ERK and p38 MAP kinase Int. Immunopharmacol. 11 1 2011 141 144 10.1016/j.intimp.2010.10.010 21035435
82 Poiraud C. Quereux G. Knol A.C. Zuliani T. Allix R. Khammari A. Human beta-defensin-2 and psoriasin, two new innate immunity targets of zinc gluconate Eur. J. Dermatol. 22 5 2012 634 639 10.1684/ejd.2012.1800 22854010
83 Harder J. Meyer-Hoffert U. Wehkamp K. Schwichtenberg L. Schröder J.M. Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid J. Invest. Dermatol. 123 3 2004 522 529 10.1111/j.0022-202X.2004.23234.x 15304092
84 Abiko Y. Nishimura M. Kusano K. Yamazaki M. Arakawa T. Takuma T. Upregulated expression of human beta defensin-1 and -3 mRNA during differentiation of keratinocyte immortalized cell lines, HaCaT and PHK16-0b J. Dermatol. Sci. 31 3 2003 225 228 10.1016/s0923-1811(03)00007-0 12727027
85 Peric M. Koglin S. Dombrowski Y. Gross K. Bradac E. Ruzicka T. VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid Mol. Immunol. 46 16 2009 3183 3187 10.1016/j.molimm.2009.08.010 19733911
86 D’Aldebert E. Biyeyeme Bi Mve M.J. Mergey M. Wendum D. Firrincieli D. Coilly A. Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium Gastroenterology 136 4 2009 1435 1443 10.1053/j.gastro.2008.12.040 19245866
87 Hochberg A. Patz M. Karrasch T. Schäffler A. Schmid A. Serum levels and adipose tissue gene expression of cathelicidin antimicrobial peptide (CAMP) in obesity and during weight loss, Horm Metab. Res. 53 3 2021 169 177 10.1055/a-1323-3050
88 Lombardo T.B. Feghali K. Zhao L. Palomari Spolidorio D.M. Grenier D. Green tea extract and its major constituent, epigallocatechin-3-gallate, induce epithelial beta-defensin secretion and prevent beta-defensin degradation by Porphyromonas gingivalis J. Periodontal. Res. 49 5 2014 615 623 10.1111/jre.12142 24206194
89 Mou Q. Jiang Y. Zhu L. Zhu Z. Ren T. EGCG induces β-defensin 3 against influenza A virus H1N1 by the MAPK signaling pathway Exp. Ther. Med. 20 4 2020 3017 3024 10.3892/etm.2020.9047 32855668
90 Wan M.L. Ling K.H. Wang M.F. El-Nezami H. Green tea polyphenol epigallocatechin-3-gallate improves epithelial barrier function by inducing the production of antimicrobial peptide pBD-1 and pBD-2 in monolayers of porcine intestinal epithelial IPEC-J2 cells Mol. Nutr. Food Res. 60 5 2016 1048 1058 10.1002/mnfr.201500992 26991948
91 Yang Q. Burkardt A.C. Sunkara L.T. Xiao K. Zhang G. Natural cyclooxygenase-2 inhibitors synergize with butyrate to augment chicken host defense peptide gene expression Front. Immunol. 13 2022 819222 10.3389/fimmu.2022.819222
92 Bayele H.K. Balesaria S. Srai S.K. Phytoestrogens modulate hepcidin expression by Nrf2: implications for dietary control of iron absorption Free Radic. Biol. Med. 89 2015 1192 1202 10.1016/j.freeradbiomed.2015.11.001 26546695
93 Ying L. Wu H. Zhou S. Lu H. Ding M. Wang B. Toll-like receptors signaling pathway of quercetin regulating avian beta-defensin in the ileum of broilers Front. Cell Dev. Biol. 10 2022 816771 10.3389/fcell.2022.816771
94 Wang J. Zhang C. Zhang J. Xie J. Yang L. Xing Y. The effects of quercetin on immunity, antioxidant indices, and disease resistance in zebrafish (Danio rerio) Fish Physiol. Biochem. 46 2 2020 759 770 10.1007/s10695-019-00750-2 31897859
95 Min S.Y. Park C.H. Yu H.W. Park Y.J. Anti-inflammatory and anti-allergic effects of saponarin and its impact on signaling pathways of RAW 264.7, RBL-2H3, and HaCaT cells Int. J. Mol. Sci. 22 16 2021 8432 10.3390/ijms22168431 34445133
96 Park C.H. Min S.Y. Yu H.W. Kim K. Kim S. Lee H.J. Effects of apigenin on RBL-2H3, RAW264.7, and HaCaT cells: anti-allergic, anti-inflammatory, and skin-protective activities Int. J. Mol. Sci. 21 13 2020 4620 10.3390/ijms21134620 32610574
97 Park K. Kim Y.I. Shin K.O. Seo H.S. Kim J.Y. Mann T. The dietary ingredient, genistein, stimulates cathelicidin antimicrobial peptide expression through a novel S1P-dependent mechanism J. Nutr. Biochem. 25 7 2014 734 740 10.1016/j.jnutbio.2014.03.005 24768661
98 Wang J. Lyu W. Zhang W. Chen Y. Luo F. Wang Y. Discovery of natural products capable of inducing porcine host defense peptide gene expression using cell-based high throughput screening J. Anim. Sci. Biotechnol. 12 1 2021 14 10.1186/s40104-020-00536-0 33431034
99 Lyu W. Deng Z. Sunkara L.T. Becker S. Robinson K. Matts R. High throughput screening for natural host defense peptide-inducing compounds as novel alternatives to antibiotics Front. Cell Infect. Microbiol. 8 2018 191 10.3389/fcimb.2018.00191 29942796
100 Sechet E. Telford E. Bonamy C. Sansonetti P.J. Sperandio B. Natural molecules induce and synergize to boost expression of the human antimicrobial peptide beta-defensin-3 Proc. Natl. Acad. Sci. U.S.A. 115 42 2018 E9869 E9878 10.1073/pnas.1805298115 30275324
101 Lee S.I. Park K.H. Kim S.J. Kang Y.G. Lee Y.M. Mechanical stress-activated immune response genes via sirtuin 1 expression in human periodontal ligament cells Clin. Exp. Immunol. 168 1 2012 113 124 10.1111/j.1365-2249.2011.04549.x 22385246
102 Park K. Elias P.M. Hupe M. Borkowski A.W. Gallo R.L. Shin K.O. Resveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production J Invest Dermatol 133 8 2013 1942 1949 10.1038/jid.2013.133 23856934
103 Guo C. Sinnott B. Niu B. Lowry M.B. Fantacone M.L. Gombart A.F. Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids Mol. Nutr. Food Res. 58 3 2014 528 536 10.1002/mnfr.201300266 24039193
104 Zhuang Y. Huang H. Liu S. Liu F. Tu Q. Yin Y. He S. Resveratrol improves growth performance, intestinal morphology, and microbiota composition and metabolism in mice Front. Microbiol. 12 2021 726878 10.3389/fmicb.2021.726878
105 Ravagnan G. De Filippis A. Cartenì M. De Maria S. Cozza V. Petrazzuolo M. Polydatin, a natural precursor of resveratrol, induces beta-defensin production and reduces inflammatory response Inflammation 36 1 2013 26 34 10.1007/s10753-012-9516-8 22956122
106 Promsong A. Chung W.O. Satthakarn S. Nittayananta W. Ellagic acid modulates the expression of oral innate immune mediators: potential role in mucosal protection J. Oral Pathol. Med. 44 3 2015 214 221 10.1111/jop.12223 25047680
107 de Barros P.P. Rossoni R.D. Garcia M.T. Kaminski V.L. Loures F.V. Fuchs B.B. The anti-biofilm efficacy of caffeic acid phenethyl ester (CAPE) in vitro and a murine model of oral candidiasis Front. Cell. Infect. Microbiol. 11 2021 700305 10.3389/fcimb.2021.700305
108 Guo C. Rosoha E. Lowry M.B. Borregaard N. Gombart A.F. Curcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin D receptor-independent pathway J. Nutr. Biochem. 24 5 2013 754 759 10.1016/j.jnutbio.2012.04.002 22841393
109 Ming J. Ye J. Zhang Y. Xu Q. Yang X. Shao X. Optimal dietary curcumin improved growth performance, and modulated innate immunity, antioxidant capacity and related genes expression of NF-κB and Nrf2 signaling pathways in grass carp (Ctenopharyngodon idella) after infection with Aeromonas hydrophila Fish Shellfish Immunol 97 2020 540 553 10.1016/j.fsi.2019.12.074 31881329
110 Chakraborty K. Maity P.C. Sil A.K. Takeda Y. Das S. cAMP stringently regulates human cathelicidin antimicrobial peptide expression in the mucosal epithelial cells by activating cAMP-response element-binding protein, AP-1, and inducible cAMP early repressor J. Biol. Chem. 284 33 2009 21810 21827 10.1074/jbc.M109.001180 19531482
111 Yin L. Chung W.O. Epigenetic regulation of human beta-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria Mucosal Immunol 4 4 2011 409 419 10.1038/mi.2010.83 21248725
112 Fischer N. Sechet E. Friedman R. Amiot A. Sobhani I. Nigro G. Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge Proc. Natl. Acad. Sci. U.S.A. 113 21 2016 E2993 E3001 10.1073/pnas.1605997113 27162363
113 Lee J. Jang A. Kim J.W. Han J.H. Chun B.H. Jung H.S. Distinct histone modifications modulate DEFB1 expression in human vaginal keratinocytes in response to Lactobacillus spp Probiotics Antimicrob. Proteins 9 4 2017 406 414 10.1007/s12602-017-9286-6 28508168
114 Deng Z. Wang J. Lyu W. Wieneke X. Matts R. Ma X. Development of a cell-based high-throughput screening assay to identify porcine host defense peptide-inducing compounds J. Immunol. Res. 2018 2018 5492941 10.1155/2018/5492941
115 Kweh M.F. Merriman K.E. Nelson C.D. Short communication: inhibition of DNA methyltransferase and histone deacetylase increases beta-defensin expression but not the effects of lipopolysaccharide or 1,25-dihydroxyvitamin D3 in bovine mammary epithelial cells J. Dairy Sci. 102 6 2019 5706 5712 10.3168/jds.2018-16141 30954263
116 Sangeeta K. Yenugu S. Male reproductive tract antimicrobial expression in the extremes of ages of rats Gene 710 2019 218 232 10.1016/j.gene.2019.05.053 31158448
117 Roy G. Brar H.K. Muthuswami R. Madhubala R. Epigenetic regulation of defense genes by histone deacetylase1 in human cell line-derived macrophages promotes intracellular survival of Leishmania donovani PLoS Negl. Trop. Dis. 14 4 2020 e0008167 10.1371/journal.pntd.0008167
118 Stebe-Frick S. Ostaff M.J. Stange E.F. Malek N.P. Wehkamp J. Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue Sci. Rep. 8 1 2018 12886 10.1038/s41598-018-31125-x
119 Zhou Y. Wang Q. Yang Q. Tang J. Xu C. Gai D. Histone deacetylase 3 inhibitor suppresses hepatitis C virus replication by regulating Apo-A1 and LEAP-1 expression Virol. Sin. 33 5 2018 418 428 10.1007/s12250-018-0057-7 30328580
120 Whitmore M.A. Li H. Lyu W. Khanam S. Zhang G. Epigenetic regulation of host defense peptide synthesis: synergy between histone deacetylase inhibitors and DNA/histone methyltransferase inhibitors Front. Immunol. 13 2022 874706 10.3389/fimmu.2022.874706
121 Ottosson H. Nylén F. Sarker P. Miraglia E. Bergman P. Gudmundsson G.H. Potent inducers of endogenous antimicrobial peptides for host directed therapy of infections Sci. Rep. 6 2016 36692 10.1038/srep36692
122 Miraglia E. Nylén F. Johansson K. Arnér E. Cebula M. Farmand S. Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1alpha transcription factors Sci. Rep. 6 2016 33274 10.1038/srep33274
123 Sarker P. Banik A. Stromberg R. Gudmundsson G.H. Raqib R. Agerberth B. Treatment with entinostat heals experimental cholera by affecting physical and chemical barrier functions of intestinal epithelia Antimicrob. Agents Chemother. 61 7 2017 e02570-16 10.1128/AAC.02570-16
124 Deng Z. Lyu W. Zhang G. High-throughput identification of epigenetic compounds to enhance chicken host defense peptide gene expression Antibiotics. (Basel) 11 7 2022 933 10.3390/antibiotics11070933 35884187
125 Myszor I.T. Parveen Z. Ottosson H. Bergman P. Agerberth B. Strömberg R. Novel aroylated phenylenediamine compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity Sci. Rep. 9 1 2019 7114 10.1038/s41598-019-43350-z 31068616
126 Lyu W. Mi D. Vinson P.N. Xiao Y. Zhang G. Large-scale identification of multiple classes of host defense peptide-inducing compounds for antimicrobial therapy Int. J. Mol. Sci. 23 15 2022 8400 10.3390/ijms23158400 35955551
127 Kamino Y. Kurashige Y. Uehara O. Sato J. Nishimura M. Yoshida K. HBD-2 is downregulated in oral carcinoma cells by DNA hypermethylation, and increased expression of hBD-2 by DNA demethylation and gene transfection inhibits cell proliferation and invasion Oncol. Rep. 32 2 2014 462 468 10.3892/or.2014.3260 24927104
128 Chen X. Qi G. Qin M. Zou Y. Zhong K. Tang Y. DNA methylation directly downregulates human cathelicidin antimicrobial peptide gene (CAMP) promoter activity Oncotarget 8 17 2017 27943 27952 10.18632/oncotarget.15847 28427192
129 Wang G. Li Y. Yang G. Yang T. He L. Wang Y. Cathelicidin antimicrobial peptide (CAMP) gene promoter methylation induces chondrocyte apoptosis Hum. Genomics. 15 1 2021 24 10.1186/s40246-021-00321-8 33892795
130 Kausar S. Abbas M.N. Gul I. Liu R. Li Q. Zhao E. Molecular identification of two DNA methyltransferase genes and their functional characterization in the anti-bacterial immunity of Antheraea pernyi Front. Immunol. 13 2022 855888 10.3389/fimmu.2022.855888
131 Ghadimi D. Hassan M. Njeru P.N. de Vrese M. Geis A. Shalabi S.I. Suppression subtractive hybridization identifies bacterial genomic regions that are possibly involved in hBD-2 regulation by enterocytes Mol. Nutr. Food Res. 55 10 2011 1533 1542 10.1002/mnfr.201100052 21710560
132 Messaoudi S. Madi A. Prévost H. Feuilloley M. Manai M. Dousset X. In vitro evaluation of the probiotic potential of Lactobacillus salivarius SMXD51 Anaerobe 18 6 2012 584 589 10.1016/j.anaerobe.2012.10.004 23122647
133 Paparo L. Aitoro R. Nocerino R. Fierro C. Bruno C. Canani R.B. Direct effects of fermented cow’s milk product with Lactobacillus paracasei CBA L74 on human enterocytes Benef. Microbes. 9 1 2018 165 172 10.3920/BM2017.0038 29065709
134 Kobatake E. Kabuki T. S-layer protein of Lactobacillus helveticus SBT2171 promotes human β-defensin 2 expression via TLR2–JNK signaling Front. Microbiol. 10 2019 2414 10.3389/fmicb.2019.02414 31681252
135 Kobatake E. Kobayashi R. Kabuki T. Kurita-Ochiai T. Lactobacillus helveticus SBT2171 upregulates the expression of β-defensin and ameliorates periodontal disease caused by Porphyromonas gingivalis Microbiol. Immunol. 63 8 2019 293 302 10.1111/1348-0421.12719 31209914
136 Huang F.C. Lu Y.T. Liao Y.H. Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation Innate Immun 26 7 2020 592 600 10.1177/1753425920959410 32988256
137 Pahumunto N. Duangnumsawang Y. Teanpaisan R. Effects of potential probiotics on the expression of cytokines and human beta-defensins in human gingival epithelial cells and in vivo efficacy in a dog model Arch. Oral. Biol. 142 2022 105513 10.1016/j.archoralbio.2022.105513
138 Miquel S. Verlaguet J. Garcin S. Bertran T. Evrard B. Forestier C. Vareille-Delarbre M. Lacticaseibacillus rhamnosus Lcr35 stimulates epithelial vaginal defenses upon Gardnerella vaginalis infection Infect. Immun. 90 9 2022 e0030922 10.1128/iai.00309-22
139 Rizzo A. Losacco A. Carratelli C.R. Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through toll-like receptors 2 and 4, interleukin 8 and human beta-defensins 2 and 3 Immunol. Lett. 156 1–2 2013 102 109 10.1016/j.imlet.2013.08.013 24120511
140 Rosignoli C. Thibaut de Ménonville S. Orfila D. Béal M. Bertino B. Aubert J. A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model Exp. Dermatol. 27 4 2018 358 365 10.1111/exd.13504 29380443
141 Moro-García M.A. Alonso-Arias R. Baltadjieva M. Fernández Benítez C. Fernández Barrial M.A. Díaz Ruisánchez E. Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects Age 35 4 2013 1311 1326 10.1007/s11357-012-9434-6 22645023
142 Nocerino R. De Filippis F. Cecere G. Marino A. Micillo M. Di Scala C. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: a randomised, double blind, placebo-controlled trial, Aliment Pharmacol. Ther. 51 1 2020 110 120 10.1111/apt.15561
143 Schlee M. Harder J. Köten B. Stange E.F. Wehkamp J. Fellermann K. Probiotic Lactobacilli and VSL#3 induce enterocyte beta-defensin 2 Clin. Exp. Immunol. 151 3 2008 528 535 10.1111/j.1365-2249.2007.03587.x 18190603
144 Hrdý J. Alard J. Couturier-Maillard A. Boulard O. Boutillier D. Delacre M. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses Sci. Rep. 10 1 2020 5345 10.1038/s41598-020-62161-1 32210304
145 Sánchez E. Nieto J.C. Vidal S. Santiago A. Martinez X. Sancho F.J. Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride Sci. Rep. 7 2017 45712 10.1038/srep45712
146 Aktas B. De Wolfe T.J. Safdar N. Darien B.J. Steele J.L. The Impact of Lactobacillus casei on the composition of the cecal microbiota and innate immune system is strain specific PLoS One 11 5 2016 e0156374 10.1371/journal.pone.0156374
147 Wang J. Zhang W. Wang S. Liu H. Zhang D. Wang Y. Swine-derived probiotic Lactobacillus plantarum modulates porcine intestinal endogenous host defense peptide synthesis through TLR2/MAPK/AP-1 signaling pathway Front. Immunol. 10 2019 2691 10.3389/fimmu.2019.02691 31803195
148 Wang J. Ji H. Wang S. Liu H. Zhang W. Zhang D. Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota Front. Microbiol. 9 2018 1953 10.3389/fmicb.2018.01953 30197632
149 Shen J. Zhang J. Zhao Y. Lin Z. Ji L. Ma X. Tibetan pig-derived probiotic Lactobacillus amylovorus SLZX20-1 improved intestinal function via producing enzymes and regulating intestinal microflora Front. Nutr. 9 2022 846991 10.3389/fnut.2022.846991
150 Sudan S. Zhan X. Li J. A novel probiotic Bacillus subtilis strain confers cytoprotection to host pig intestinal epithelial cells during enterotoxic Escherichia coli infection Microbiol. Spectr. 10 4 2022 e0125721 10.1128/spectrum.01257-21
151 Deng J. Li Y. Zhang J. Yang Q. Co-administration of Bacillus subtilis RJGP16 and Lactobacillus salivarius B1 strongly enhances the intestinal mucosal immunity of piglets Res. Vet. Sci. 94 1 2013 62 68 10.1016/j.rvsc.2012.07.025 22901748
152 Wang Y. Gong L. Wu Y.P. Cui Z.W. Wang Y.Q. Huang Y. Oral administration of Lactobacillus rhamnosus GG to newborn piglets augments gut barrier function in pre-weaning piglets J. Zhejiang Univ. Sci. B. 20 2 2019 180 192 10.1631/jzus.B1800022 30666850
153 Terada T. Nii T. Isobe N. Yoshimura Y. Effects of probiotics Lactobacillus reuteri and Clostridium butyricum on the expression of toll-like receptors, pro- and anti-inflammatory cytokines, and antimicrobial peptides in broiler chick intestine J. Poult. Sci. 57 4 2020 310 318 10.2141/jpsa.0190098 33132732
154 Souza R.F.S. Rault L. Seyffert N. Azevedo V. Le Loir Y. Even S. Lactobacillus casei BL23 modulates the innate immune response in Staphylococcus aureus-stimulated bovine mammary epithelial cells Benef. Microbes. 9 6 2018 985 995 10.3920/BM2018.0010 30041534
155 Bach A. Guasch I. Elcoso G. Chaucheyras-Durand F. Castex M. Fàbregas F. Changes in gene expression in the rumen and colon epithelia during the dry period through lactation of dairy cows and effects of live yeast supplementation J. Dairy Sci. 101 3 2018 2631 2640 10.3168/jds.2017-13212 29290424
156 Chen K. Chen H. Faas M.M. de Haan B.J. Li J. Xiao P. Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis Mol. Nutr. Food Res. 61 8 2017 1601006 10.1002/mnfr.201601006
157 Xie S.Z. Liu B. Ye H.Y. Li Q.M. Pan L.H. Zha X.Q. Dendrobium huoshanense polysaccharide regionally regulates intestinal mucosal barrier function and intestinal microbiota in mice Carbohydr. Polym. 206 2019 149 162 10.1016/j.carbpol.2018.11.002 30553308
158 Raqib R. Sarker P. Mily A. Alam N.H. Arifuzzaman A.S. Rekha R.S. Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial BMC Infect. Dis. 12 2012 111 10.1186/1471-2334-12-111 22574737
159 Hinnebusch B.F. Meng S. Wu J.T. Archer S.Y. Hodin R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation J. Nutr. 132 5 2002 1012 1017 11983830
160 Zhao Y. Chen F. Wu W. Sun M. Bilotta A.J. Yao S. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3 Mucosal Immunol 11 3 2018 752 762 10.1038/mi.2017.118 29411774
161 Chakraborty K. Ghosh S. Koley H. Mukhopadhyay A.K. Ramamurthy T. Saha D.R. Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells Cell Microbiol 10 12 2008 2520 2537 10.1111/j.1462-5822.2008.01227.x 18717821
162 Selvaraj P. Prabhu Anand S. Harishankar M. Alagarasu K. Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin D receptor and cathelicidin in pulmonary tuberculosis J. Clin. Immunol. 29 4 2009 470 478 10.1007/s10875-009-9277-9 19219539
163 Sato-Deguchi E. Imafuku S. Chou B. Ishii K. Hiromatsu K. Nakayama J. Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions Br. J. Dermatol. 167 1 2012 77 84 10.1111/j.1365-2133.2012.10917.x 22384824
164 Muehleisen B. Bikle D.D. Aguilera C. Burton D.W. Sen G.L. Deftos L.J. Gallo R.L. PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection Sci. Transl. Med. 4 135 2012 135ra66 10.1126/scitranslmed.3003759
165 Kanda N. Hau C.S. Tada Y. Sato S. Watanabe S. Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M Allergy 67 6 2012 804 812 10.1111/j.1398-9995.2012.02824.x 22486751
166 Finklea J.D. Grossmann R.E. Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies Adv. Nutr. 2 3 2011 244 253 10.3945/an.111.000398 22332056
167 Aibana O. Huang C.C. Aboud S. Arnedo-Pena A. Becerra M.C. Bellido-Blasco J.B. Vitamin D status and risk of incident tuberculosis disease: a nested case-control study, systematic review, and individual-participant data meta-analysis PLoS Med 16 9 2019 e1002907 10.1371/journal.pmed.1002907
168 Ganmaa D. Uyanga B. Zhou X. Gantsetseg G. Delgerekh B. Enkhmaa D. Vitamin D supplements for prevention of tuberculosis infection and disease N. Engl. J. Med. 383 4 2020 359 368 10.1056/NEJMoa1915176 32706534
169 Tian G. Liang X. Chen D. Mao X. Yu J. Zheng P. Vitamin D3 supplementation alleviates Rotavirus infection in pigs and IPEC-J2 cells via regulating the autophagy signaling pathway J. Steroid Biochem. Mol. Biol. 163 2016 157 163 10.1016/j.jsbmb.2016.05.004 27174720
170 Coyle C. Wheelhouse N. Jacques M. Longbottom D. Svoboda P. Pohl J. Ovine trophoblasts express cathelicidin host defence peptide in response to infection J. Reprod. Immunol. 117 2016 10 16 10.1016/j.jri.2016.06.006 27348190
171 Wei R. Dhawan P. Baiocchi R.A. Kim K.Y. Christakos S. PU.1 and epigenetic signals modulate 1,25-dihydroxyvitamin D3 and C/EBPalpha regulation of the human cathelicidin antimicrobial peptide gene in lung epithelial cells J. Cell Physiol. 234 7 2019 10345 10359 10.1002/jcp.27702 30387140
172 Mielke L.A. Jones S.A. Raverdeau M. Higgs R. Stefanska A. Groom J.R. Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation J. Exp. Med. 210 6 2013 1117 1124 10.1084/jem.20121588 23690441
173 Wu H. Zhang G. Minton J.E. Ross C.R. Blecha F. Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection Infect. Immun. 68 10 2000 5552 5558 10.1128/IAI.68.10.5552-5558.2000 10992453
174 Grubor B. Meyerholz D.K. Lazic T. DeMacedo M.M. Derscheid R.J. Hostetter J.M. Regulation of surfactant protein and defensin mRNA expression in cultured ovine type II pneumocytes by all-trans retinoic acid and VEGF Int. J. Exp. Pathol. 87 5 2006 393 403 10.1111/j.1365-2613.2006.00494.x 16965567
175 Ren M. Cai S. Zhou T. Zhang S. Li S. Jin E. Isoleucine attenuates infection induced by E. coli challenge through the modulation of intestinal endogenous antimicrobial peptide expression and the inhibition of the increase in plasma endotoxin and IL-6 in weaned pigs Food Funct 10 6 2019 3535 3542 10.1039/c9fo00218a 31149689
176 Tsugami Y. Nii T. Isobe N. Valine treatment enhances antimicrobial component production in mammary epithelial cells and the milk of lactating goats without influencing the tight junction barrier J. Mammary Gland Biol. Neoplasia 28 1 2023 3 10.1007/s10911-023-09529-x 36801983
177 Tang Z. Shi B. Sun W. Yin Y. Chen Q. Mohamed T. Tryptophan promoted β-defensin-2 expression via the mTOR pathway and its metabolites: kynurenine banding to aryl hydrocarbon receptor in rat intestine RSC Adv 10 6 2020 3371 3379 10.1039/c9ra10477a 35497743
178 Lan J. Dou X. Li J. Yang Y. Xue C. Wang C. L-Arginine ameliorates lipopolysaccharide-induced intestinal inflammation through inhibiting the TLR4/NF-κB and MAPK pathways and stimulating β-defensin expression in vivo and in vitro J. Agric. Food Chem. 68 9 2020 2648 2663 10.1021/acs.jafc.9b07611 32064872
179 Yin J. Yu F.S. LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas Invest. Ophthalmol. Vis. Sci. 51 4 2010 1891 1897 10.1167/iovs.09-3904 19797203
180 Lan C.C. Wu C.S. Huang S.M. Kuo H.Y. Wu I.H. Liang C.W. High-glucose environment reduces human beta-defensin-2 expression in human keratinocytes: implications for poor diabetic wound healing Br. J. Dermatol. 166 6 2012 1221 1229 10.1111/j.1365-2133.2012.10847.x 22283836
181 Wessels I. Fischer H.J. Rink L. Dietary and physiological effects of zinc on the immune system Annu. Rev. Nutr. 41 2021 133 175 10.1146/annurev-nutr-122019-120635 34255547
182 Kelly P. Feakins R. Domizio P. Murphy J. Bevins C. Wilson J. Paneth cell granule depletion in the human small intestine under infective and nutritional stress Clin. Exp. Immunol. 135 2 2004 303 309 10.1111/j.1365-2249.2004.02374.x 14738460
183 Zhong W. Wei X. Hao L. Lin T.D. Yue R. Sun X. Paneth cell dysfunction mediates alcohol-related steatohepatitis through promoting bacterial translocation in mice: role of zinc deficiency Hepatology 71 5 2020 1575 1591 10.1002/hep.30945 31520476
184 Krisanaprakornkit S. Jotikasthira D. Dale B.A. Intracellular calcium in signaling human beta-defensin-2 expression in oral epithelial cells J. Dent. Res. 82 11 2003 877 882 10.1177/154405910308201106 14578498
185 Mader J.S. Mookherjee N. Hancock R.E. Bleackley R.C. The human host defense peptide LL-37 induces apoptosis in a calpain- and apoptosis-inducing factor-dependent manner involving Bax activity Mol. Cancer Res. 7 5 2009 689 702 10.1158/1541-7786.MCR-08-0274 19435812
186 Vylkova S. Nayyar N. Li W. Edgerton M. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption Antimicrob. Agents Chemother. 51 1 2007 154 161 10.1128/AAC.00478-06 17074797
187 Fuchs C.D. Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology Nat. Rev. Gastroenterol. Hepatol. 19 7 2022 432 450 10.1038/s41575-021-00566-7 35165436
188 Wang S. Du Q. Meng X. Zhang Y. Natural polyphenols: a potential prevention and treatment strategy for metabolic syndrome Food Funct 13 19 2022 9734 9753 10.1039/d2fo01552h 36134531
189 Tobin I. Zhang G. Regulation of host defense peptide synthesis by polyphenols Antibiotics (Basel) 12 4 2023 660 10.3390/antibiotics12040660 37107022
190 Noguchi T. Shiba H. Komatsuzawa H. Mizuno N. Uchida Y. Ouhara K. Syntheses of prostaglandin E2 and E-cadherin and gene expression of beta-defensin-2 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans Inflammation 27 6 2003 341 349 10.1023/b:ifla.0000006702.27906.e9 14760942
191 Perri F. Longo F. Giuliano M. Sabbatino F. Favia G. Ionna F. Epigenetic control of gene expression: potential implications for cancer treatment Crit. Rev. Oncol. Hematol. 111 2017 166 172 10.1016/j.critrevonc.2017.01.020 28259291
192 Lyu W. Deng Z. Zhang G. High-throughput screening for epigenetic compounds that induce human beta-defensin 1 synthesis Antibiotics. (Basel) 12 2 2023 186 10.3390/antibiotics12020186 36830097
193 Bouyahya A. El Hachlafi N. Aanniz T. Bourais I. Mechchate H. Benali T. Natural bioactive compounds targeting histone deacetylases in human cancers: recent updates Molecules 27 8 2022 2568 10.3390/molecules27082568 35458763
194 Akone S.H. Ntie-Kang F. Stuhldreier F. Ewonkem M.B. Noah A.M. Mouelle S.E.M. Natural products impacting DNA methyltransferases and histone deacetylases Front. Pharmacol. 11 2020 992 10.3389/fphar.2020.00992 32903500
195 Barrier M.L. Myszor I.T. Sahariah P. Sigurdsson S. Carmena-Bargueño M. Pérez-Sánchez H. Aroylated phenylenediamine HO53 modulates innate immunity, histone acetylation and metabolism Mol. Immunol. 155 2023 153 164 10.1016/j.molimm.2023.02.003 36812763
196 Gschwandtner M. Zhong S. Tschachler A. Mlitz V. Karner S. Elbe-Burger A. Fetal human keratinocytes produce large amounts of antimicrobial peptides: involvement of histone-methylation processes J. Invest. Dermatol. 134 8 2014 2192 2201 10.1038/jid.2014.165 24694903
197 Latif A. Shehzad A. Niazi S. Zahid A. Ashraf W. Iqbal M.W. Probiotics: mechanism of action, health benefits and their application in food industries Front. Microbiol. 14 2023 1216674 10.3389/fmicb.2023.1216674
198 Wehkamp J. Harder J. Wehkamp K. Wehkamp-von Meissner B. Schlee M. Enders C. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium Infect. Immun. 72 10 2004 5750 5758 10.1128/IAI.72.10.5750-5758.2004 15385474
199 Li X. Song L. Zhu S. Xiao Y. Huang Y. Hua Y. Two strains of Lactobacilli effectively decrease the colonization of VRE in a mouse model Front. Cell Infect. Microbiol. 9 2019 6 10.3389/fcimb.2019.00006 30761273
200 Liu H. Hou C. Wang G. Jia H. Yu H. Zeng X. Lactobacillus reuteri I5007 modulates intestinal host defense peptide expression in the model of IPEC-J2 cells and neonatal piglets Nutrients 9 6 2017 559 10.3390/nu9060559 28561758
201 Wang M. Wu H. Lu L. Jiang L. Yu Q. Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets Front. Vet. Sci. 7 2020 42 10.3389/fvets.2020.00042 32118065
202 Nii T. Jirapat J. Isobe N. Yoshimura Y. Effects of oral administration of Lactobacillus reuteri on mucosal barrier function in the digestive tract of broiler chicks J. Poult. Sci. 57 1 2020 67 76 10.2141/jpsa.0190035 32174767
203 Jin X. Zhang M. Yang Y.F. Saccharomyces cerevisiae β-glucan-induced SBD-1 expression in ovine ruminal epithelial cells is mediated through the TLR-2-MyD88-NF-κB/MAPK pathway Vet. Res. Commun. 43 2 2019 77 89 10.1007/s11259-019-09747-x 30863917
204 Strunk T. Hibbert J. Doherty D. Granland C. Trend S. Simmer K. Probiotics and antimicrobial protein and peptide levels in preterm infants, Acta Paediatr. 106 11 2017 1747 1753 10.1111/apa.13826
205 Wu S. Yoon S. Zhang Y.G. Lu R. Xia Y. Wan J. Vitamin D receptor pathway is required for probiotic protection in colitis Am. J. Physiol. Gastrointest. Liver Physiol. 309 5 2015 G341 G349 10.1152/ajpgi.00105.2015 26159695
206 Coussens A.K. Wilkinson R.J. Martineau A.R. Phenylbutyrate is bacteriostatic against Mycobacterium tuberculosis and regulates the macrophage response to infection, synergistically with 25-hydroxy-vitamin D3 PLoS. Pathog. 11 7 2015 e1005007 10.1371/journal.ppat.1005007
207 van der Does A.M. Kenne E. Koppelaar E. Agerberth B. Lindbom L. Vitamin D3 and phenylbutyrate promote development of a human dendritic cell subset displaying enhanced antimicrobial properties J. Leukoc. Biol. 95 6 2014 883 891 10.1189/jlb.1013549 24550524
208 Yim S. Dhawan P. Ragunath C. Christakos S. Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3) J. Cyst. Fibros. 6 6 2007 403 410 10.1016/j.jcf.2007.03.003 17467345
209 Yang Q. Whitmore M.A. Robinson K. Lyu W. Zhang G. Butyrate, forskolin, and lactose synergistically enhance disease resistance by inducing the expression of the genes involved in innate host defense and barrier function Antibiotics. (Basel). 10 10 2021 1175 10.3390/antibiotics10101175 34680756
210 Cederlund A. Nylén F. Miraglia E. Bergman P. Gudmundsson G.H. Agerberth B. Label-free quantitative mass spectrometry reveals novel pathways involved in LL-37 expression J. Innate Immun 6 3 2014 365 376 10.1159/000355931 24246949
